RxNorm Semantic Concepts Index - 130
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "130".
RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
---|---|---|---|---|
RxCUI: 1300000 | Siberian elm pollen extract 20000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300000 | Siberian elm pollen extract 20000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300000 | Siberian elm pollen extract 20000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300001 | Siberian elm pollen extract 40000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300002 | Siberian elm pollen extract 40000 UNT/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300002 | Siberian elm pollen extract 40000 UNT/mL Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300002 | Siberian elm pollen extract 40000 UNT/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300005 | ISOtretinoin 20 MG [Absorica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300005 | ISOtretinoin 20 MG [Absorica] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300006 | Absorica 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300006 | Absorica 20 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300006 | Absorica 20 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300006 | Absorica 20 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300013 | ISOtretinoin 30 MG [Absorica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300013 | ISOtretinoin 30 MG [Absorica] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300014 | Absorica 30 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300014 | Absorica 30 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300014 | Absorica 30 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300014 | Absorica 30 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300015 | ISOtretinoin 40 MG [Absorica] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300015 | ISOtretinoin 40 MG [Absorica] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300016 | Absorica 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300016 | Absorica 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300016 | Absorica 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300016 | Absorica 40 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300017 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300017 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300017 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300020 | guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300020 | guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300020 | guaiFENesin 400 MG / pseudoephedrine HCl 30 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1300062 | ciclopirox 7.7 MG/ML [Ciclodan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300063 | ciclopirox Topical Cream [Ciclodan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300064 | Ciclodan 0.77 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300064 | Ciclodan 0.77 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300064 | Ciclodan 0.77 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300064 | Ciclodan 0.77 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300069 | Veteran Shield 24 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300070 | benzalkonium chloride 1 MG/ML [Veteran Shield 24] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300074 | chlorhexidine gluconate 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300074 | chlorhexidine gluconate 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300074 | chlorhexidine gluconate 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300081 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300081 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300081 | brompheniramine maleate 6 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300082 | brompheniramine maleate 6 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300083 | brompheniramine maleate 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300084 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300084 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300084 | brompheniramine maleate 12 MG / pseudoephedrine HCl 120 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300085 | brompheniramine maleate 12 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300086 | glycolate 110 MG/ML [Aqua Glycolic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300087 | Aqua Glycolic 11 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300087 | Aqua Glycolic 11 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300087 | Aqua Glycolic 11 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300087 | Aqua Glycolic 11 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300089 | phenylephrine hydrochloride 25 MG/ML [AK-Dilate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300090 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [AK-Dilate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300090 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [AK-Dilate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300090 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [AK-Dilate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300091 | phenylephrine hydrochloride 25 MG/ML [Mydfrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300092 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [Mydfrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300092 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [Mydfrin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300092 | phenylephrine hydrochloride 25 MG/ML Ophthalmic Solution [Mydfrin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300102 | phenylephrine hydrochloride 100 MG/ML [AK-Dilate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300103 | phenylephrine hydrochloride 100 MG/ML Ophthalmic Solution [AK-Dilate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300103 | phenylephrine hydrochloride 100 MG/ML Ophthalmic Solution [AK-Dilate] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300103 | phenylephrine hydrochloride 100 MG/ML Ophthalmic Solution [AK-Dilate] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300153 | benzethonium chloride 2 MG/ML / benzocaine 200 MG/ML [Lanacane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300154 | benzethonium / benzocaine Topical Spray [Lanacane] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300155 | LANACANE MAXIMUM Strength 0.2 % / 20 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300155 | LANACANE MAXIMUM Strength 0.2 % / 20 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300155 | LANACANE MAXIMUM Strength 0.2 % / 20 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300155 | LANACANE MAXIMUM Strength 0.2 % / 20 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300163 | dexbrompheniramine maleate 0.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300164 | dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300164 | dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300164 | dexbrompheniramine maleate 2 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | Full form of descriptor (FN) | YES | |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | British preferred term (PTGB) | YES | |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | Designated preferred name (PT) | YES | |
RxCUI: 1300180 | Antigen of Bordetella pertussis filamentous hemagglutinin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300181 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300182 | Bordetella pertussis fimbriae 2/3 vaccine, inactivated | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300183 | Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300184 | Antigen of Bordetella pertussis pertactin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300184 | Antigen of Bordetella pertussis pertactin | Full form of descriptor (FN) | YES | |
RxCUI: 1300184 | Antigen of Bordetella pertussis pertactin | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300184 | Antigen of Bordetella pertussis pertactin | Designated preferred name (PT) | YES | |
RxCUI: 1300184 | Antigen of Bordetella pertussis pertactin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300185 | Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Full form of descriptor (FN) | YES | |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Designated preferred name (PT) | YES | |
RxCUI: 1300186 | Antigen of Bordetella pertussis toxoid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300187 | Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300188 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis fimbriae 2/3 vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1300189 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300189 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300189 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300189 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300190 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.005 MG/ML / diphtheria toxoid vaccine, inactivated 4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Adacel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300191 | Adacel 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300191 | Adacel 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300191 | Adacel 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300191 | Adacel 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300195 | dexbrompheniramine maleate 0.5 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300195 | dexbrompheniramine maleate 0.5 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300195 | dexbrompheniramine maleate 0.5 MG / dextromethorphan HBr 5 MG / phenylephrine HCl 2.5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300205 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300205 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300205 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300205 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (generic for Adacel) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300206 | Adacel 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300206 | Adacel 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300206 | Adacel 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300206 | Adacel 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300208 | brompheniramine maleate 0.4 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300211 | brompheniramine maleate 4 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300211 | brompheniramine maleate 4 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300262 | Proprinal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1300263 | ibuprofen 200 MG [Proprinal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300264 | ibuprofen Oral Tablet [Proprinal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300265 | Proprinal Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300266 | Proprinal Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300267 | Proprinal 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300267 | Proprinal 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300267 | Proprinal 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300268 | Ketodan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1300269 | ketoconazole 20 MG/ML [Ketodan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300270 | ketoconazole Topical Foam [Ketodan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300271 | Ketodan Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300272 | Ketodan 2 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300272 | Ketodan 2 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300272 | Ketodan 2 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300272 | Ketodan 2 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300275 | methyl salicylate 310 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300276 | menthol 11 % / methyl salicylate 31 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300276 | menthol 11 % / methyl salicylate 31 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300276 | menthol 11 % / methyl salicylate 31 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300277 | povidone-iodine gel 10 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300277 | povidone-iodine gel 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300277 | povidone-iodine gel 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300277 | povidone-iodine gel 10 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300277 | povidone-iodine gel 10 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300287 | histamine dihydrochloride 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300288 | histamine dihydrochloride 0.1 % / menthol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300288 | histamine dihydrochloride 0.1 % / menthol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300288 | histamine dihydrochloride 0.1 % / menthol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300289 | Alo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300290 | histamine dihydrochloride 1 MG/ML / menthol 30 MG/ML [Alo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300291 | histamine / menthol Topical Cream [Alo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300292 | Alo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300293 | Alo (histamine dihydrochloride 0.1 % / menthol 3 % ) Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300293 | Alo (histamine dihydrochloride 0.1 % / menthol 3 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300293 | Alo (histamine dihydrochloride 0.1 % / menthol 3 % ) Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300294 | benzocaine 20 % / benzethonium chloride 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300294 | benzocaine 20 % / benzethonium chloride 0.2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300294 | benzocaine 20 % / benzethonium chloride 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300295 | Lanacane Maximum Strength 20 % / 0.2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300295 | Lanacane Maximum Strength 20 % / 0.2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300295 | Lanacane Maximum Strength 20 % / 0.2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300296 | Orazinc Lozenge | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300297 | zinc gluconate 77 MG [Orazinc Lozenge] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300298 | zinc gluconate Oral Lozenge [Orazinc Lozenge] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300299 | Orazinc Lozenge Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300300 | Orazinc Lozenge Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300301 | zinc gluconate 77 MG Oral Lozenge [Orazinc Lozenge] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300301 | zinc gluconate 77 MG Oral Lozenge [Orazinc Lozenge] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300301 | zinc gluconate 77 MG Oral Lozenge [Orazinc Lozenge] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300303 | cyclopentamine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1300307 | Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300308 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300308 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300308 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300308 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Daptacel) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300309 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.01 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.01 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.006 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.02 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Daptacel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300310 | DAPTACEL vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300310 | DAPTACEL vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300310 | DAPTACEL vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300310 | DAPTACEL vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300348 | zinc sulfate 110 MG [Orazinc] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300349 | zinc sulfate Oral Tablet [Orazinc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300350 | Orazinc Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300351 | Orazinc 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300351 | Orazinc 110 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300351 | Orazinc 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300351 | Orazinc 110 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300351 | Orazinc 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300352 | zinc sulfate 220 MG [Orazinc] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300353 | zinc sulfate Oral Capsule [Orazinc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300354 | Orazinc 220 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300354 | Orazinc 220 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300354 | Orazinc 220 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300354 | Orazinc 220 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300354 | Orazinc 220 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300359 | salicylic acid 0.01 MG/MG [No Zit Sherlock] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300360 | salicylic acid Topical Gel [No Zit Sherlock] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300361 | no 'zit' sherlock correcting serum 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300361 | no 'zit' sherlock correcting serum 1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300361 | no 'zit' sherlock correcting serum 1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300361 | no 'zit' sherlock correcting serum 1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300362 | salicylic acid 0.02 MG/MG [No Zit Sherlock] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300363 | no 'zit' sherlock spot treatment 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300363 | no 'zit' sherlock spot treatment 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300363 | no 'zit' sherlock spot treatment 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300363 | no 'zit' sherlock spot treatment 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300364 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300365 | Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300366 | Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300367 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis pertactin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1300368 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300368 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300368 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300368 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300369 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.005 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.016 MG/ML / diphtheria toxoid vaccine, inactivated 5 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Boostrix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300370 | BOOSTRIX vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300370 | BOOSTRIX vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300370 | BOOSTRIX vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300370 | BOOSTRIX vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300371 | Cidacin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300372 | tolnaftate 10 MG/ML [Cidacin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300373 | tolnaftate Topical Solution [Cidacin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300374 | Cidacin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300375 | CIDACIN 1 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300375 | CIDACIN 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300375 | CIDACIN 1 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300375 | CIDACIN 1 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300377 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300377 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300377 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300377 | tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed (Tdap generic for Boostrix) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300378 | BOOSTRIX vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300378 | BOOSTRIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300378 | BOOSTRIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300378 | BOOSTRIX vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300379 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300380 | Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300381 | Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300382 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300382 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300382 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300382 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300383 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.05 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.016 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.05 MG/ML / diphtheria toxoid vaccine, inactivated 50 UNT/ML / tetanus toxoid vaccine, inactivated 20 UNT/ML [Infanrix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300384 | INFANRIX vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300384 | INFANRIX vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300384 | INFANRIX vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300384 | INFANRIX vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300385 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300385 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300385 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300385 | diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (DTaP generic for Infanrix) 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300386 | INFANRIX vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300386 | INFANRIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300386 | INFANRIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300386 | INFANRIX vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300387 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300388 | Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300389 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated / Bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1300390 | DTaP (diphtheria toxoid vaccine, inactivated 13.4 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 46.8 MCG) per 0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300390 | DTaP (diphtheria toxoid vaccine, inactivated 13.4 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 46.8 MCG) per 0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300390 | DTaP (diphtheria toxoid vaccine, inactivated 13.4 UNT / tetanus toxoid vaccine, inactivated 5 UNT / acellular pertussis vaccine, inactivated 46.8 MCG) per 0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300391 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [Tripedia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300392 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [Tripedia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300392 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [Tripedia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300392 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.0468 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0468 MG/ML / diphtheria toxoid vaccine, inactivated 13.4 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [Tripedia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300393 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300394 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300395 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML [Certiva] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300396 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension [Certiva] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300396 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension [Certiva] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300396 | Bordetella pertussis toxoid vaccine, inactivated 0.08 MG/ML / diphtheria toxoid vaccine, inactivated 30 UNT/ML / tetanus toxoid vaccine, inactivated 12 UNT/ML Injectable Suspension [Certiva] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300397 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300398 | Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300399 | Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300400 | Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300401 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300402 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML [ACEL-IMUNE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300403 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300403 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300403 | Bordetella pertussis filamentous hemagglutinin vaccine, inactivated 0.069 MG/ML / Bordetella pertussis fimbriae 2/3 vaccine, inactivated 0.0016 MG/ML / Bordetella pertussis pertactin vaccine, inactivated 0.0032 MG/ML / Bordetella pertussis toxoid vaccine, inactivated 0.0064 MG/ML / diphtheria toxoid vaccine, inactivated 18 UNT/ML / tetanus toxoid vaccine, inactivated 10 UNT/ML Injectable Suspension [ACEL-IMUNE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300436 | 12 HR carbetapentane citrate 60 MG / guaifenesin 900 MG Extended Release Oral Tablet [Duratuss CS] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300436 | 12 HR carbetapentane citrate 60 MG / guaifenesin 900 MG Extended Release Oral Tablet [Duratuss CS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300436 | 12 HR carbetapentane citrate 60 MG / guaifenesin 900 MG Extended Release Oral Tablet [Duratuss CS] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300436 | 12 HR carbetapentane citrate 60 MG / guaifenesin 900 MG Extended Release Oral Tablet [Duratuss CS] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300437 | Allfen C 5 MG / 1000 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300437 | Allfen C 5 MG / 1000 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300437 | Allfen C 5 MG / 1000 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300437 | Allfen C 5 MG / 1000 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300437 | Allfen C 5 MG / 1000 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300438 | Allfen CX 60 MG / 1000 MG 12HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300438 | Allfen CX 60 MG / 1000 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300438 | Allfen CX 60 MG / 1000 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300438 | Allfen CX 60 MG / 1000 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300438 | Allfen CX 60 MG / 1000 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300444 | hypromellose 2208 (100 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300445 | hypromellose 2208 (15000 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300446 | hypromellose 2208 (3 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300447 | hypromellose 2208 (4000 CPS) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300448 | hypromellose 2208 (100000 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300449 | hypromellose 2910 (3 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300450 | hypromellose 2910 (15 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300451 | hypromellose 2910 (15000 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300452 | hypromellose 2910 (5 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300453 | hypromellose 2910 (50 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300454 | hypromellose 2910 (6 cps) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300455 | hypromellose 2910 (4000 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300464 | Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300465 | Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300466 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for ActHIB) 0.5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300466 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for ActHIB) 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300466 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for ActHIB) 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300467 | Haemophilus influenzae type b strain 1482, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.068 MG/ML [ActHIB] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300468 | ActHIB vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300468 | ActHIB vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300468 | ActHIB vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300468 | ActHIB vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300468 | ActHIB vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300473 | Sodium folate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1300473 | Sodium folate | Designated preferred name (PT) | NO | |
RxCUI: 1300473 | Sodium folate | Full form of descriptor (FN) | NO | |
RxCUI: 1300476 | kanamycin A sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300478 | Recombinant human hyaluronidase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300478 | Recombinant human hyaluronidase | Full form of descriptor (FN) | YES | |
RxCUI: 1300478 | Recombinant human hyaluronidase | Designated preferred name (PT) | YES | |
RxCUI: 1300478 | Recombinant human hyaluronidase | Full form of descriptor (FN) | YES | |
RxCUI: 1300478 | Recombinant human hyaluronidase | Designated preferred name (PT) | YES | |
RxCUI: 1300479 | Methyl aminolevulinate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300479 | Methyl aminolevulinate hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 1300479 | Methyl aminolevulinate hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1300480 | methyl aminolevulinate hydrochloride 168 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300481 | methyl aminolevulinate HCl 16.8 % Topical Cream | Designated preferred name (PT) | YES | |
RxCUI: 1300481 | methyl aminolevulinate HCl 16.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300481 | methyl aminolevulinate HCl 16.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300481 | methyl aminolevulinate HCl 16.8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300481 | methyl aminolevulinate HCl 16.8 % Topical Cream | Full form of descriptor (FN) | YES | |
RxCUI: 1300482 | methyl aminolevulinate hydrochloride 168 MG/ML [Metvixia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300483 | Metvixia 16.8 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300483 | Metvixia 16.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300483 | Metvixia 16.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300483 | Metvixia 16.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300485 | Moroctocog alfa | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300485 | Moroctocog alfa | Designated preferred name (PT) | YES | |
RxCUI: 1300485 | Moroctocog alfa | Full form of descriptor (FN) | YES | |
RxCUI: 1300485 | Moroctocog alfa | Designated preferred name (PT) | YES | |
RxCUI: 1300485 | Moroctocog alfa | Full form of descriptor (FN) | YES | |
RxCUI: 1300486 | antihemophilic factor, human recombinant | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300488 | Recombinant coagulation factor IX | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300488 | Recombinant coagulation factor IX | Designated preferred name (PT) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Full form of descriptor (FN) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Designated preferred name (PT) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Full form of descriptor (FN) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Full form of descriptor (FN) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Designated preferred name (PT) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300488 | Recombinant coagulation factor IX | Full form of descriptor (FN) | YES | |
RxCUI: 1300488 | Recombinant coagulation factor IX | Designated preferred name (PT) | YES | |
RxCUI: 1300538 | DASETTA 1/35 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1300538 | DASETTA 1/35 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300538 | DASETTA 1/35 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300539 | guaiFENesin 100 MG / dextromethorphan HBr 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300539 | guaiFENesin 100 MG / dextromethorphan HBr 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1300539 | guaiFENesin 100 MG / dextromethorphan HBr 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300552 | Product containing protein C in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | YES | |
RxCUI: 1300552 | Product containing protein C in parenteral dose form (medicinal product form) | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1300552 | Product containing protein C in parenteral dose form (medicinal product form) | Designated preferred name (PT) | YES | |
RxCUI: 1300690 | benzoyl peroxide 42.5 MG/ML Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300691 | Clarifoam Clear | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300692 | benzoyl peroxide 42.5 MG/ML [Clarifoam Clear] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300693 | benzoyl peroxide Topical Foam [Clarifoam Clear] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300694 | Clarifoam Clear Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300695 | benzoyl peroxide 42.5 MG/ML Topical Foam [Clarifoam Clear] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300695 | benzoyl peroxide 42.5 MG/ML Topical Foam [Clarifoam Clear] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300695 | benzoyl peroxide 42.5 MG/ML Topical Foam [Clarifoam Clear] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300700 | lorcaserin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1300700 | lorcaserin hydrochloride | Designated preferred name (PT) | NO | |
RxCUI: 1300700 | lorcaserin hydrochloride | Full form of descriptor (FN) | NO | |
RxCUI: 1300701 | lorcaserin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1300701 | lorcaserin | Designated preferred name (PT) | NO | |
RxCUI: 1300701 | lorcaserin | Full form of descriptor (FN) | NO | |
RxCUI: 1300702 | lorcaserin hydrochloride 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300703 | lorcaserin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1300704 | lorcaserin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1300705 | lorcaserin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1300706 | lorcaserin HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300706 | lorcaserin HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300707 | Belviq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300708 | lorcaserin hydrochloride 10 MG [Belviq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300709 | lorcaserin Oral Tablet [Belviq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300710 | Belviq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300711 | Belviq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300712 | Belviq 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300712 | Belviq 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300712 | Belviq 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300712 | Belviq 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300715 | Clarifoam Pure | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300716 | salicylic acid 20 MG/ML [Clarifoam Pure] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300717 | salicylic acid Topical Cream [Clarifoam Pure] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300718 | Clarifoam Pure Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300719 | salicylic acid 20 MG/ML Topical Cream [Clarifoam Pure] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300719 | salicylic acid 20 MG/ML Topical Cream [Clarifoam Pure] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300733 | acetaminophen 162.5 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 7.5 MG / pseudoephedrine HCl 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300733 | acetaminophen 162.5 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 7.5 MG / pseudoephedrine HCl 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300733 | acetaminophen 162.5 MG / chlorpheniramine maleate 1 MG / dextromethorphan HBr 7.5 MG / pseudoephedrine HCl 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300740 | phenol 0.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300740 | phenol 0.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300740 | phenol 0.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300741 | pheniramine maleate 2.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1300742 | APAP 32 MG/ML / Pheniramine Maleate 2.6 MG/ML / Phenylephrine Hydrochloride 0.8 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300742 | APAP 32 MG/ML / Pheniramine Maleate 2.6 MG/ML / Phenylephrine Hydrochloride 0.8 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300779 | Antigen of inactivated whole Japanese encephalitis virus Nakayama-NIH strain | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300779 | Antigen of inactivated whole Japanese encephalitis virus Nakayama-NIH strain | Full form of descriptor (FN) | YES | |
RxCUI: 1300779 | Antigen of inactivated whole Japanese encephalitis virus Nakayama-NIH strain | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300779 | Antigen of inactivated whole Japanese encephalitis virus Nakayama-NIH strain | Designated preferred name (PT) | YES | |
RxCUI: 1300779 | Antigen of inactivated whole Japanese encephalitis virus Nakayama-NIH strain | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300780 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300781 | Japanese encephalitis vaccine 6 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300781 | Japanese encephalitis vaccine 6 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300781 | Japanese encephalitis vaccine 6 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300782 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML [Ixiaro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300783 | IXIARO 6 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300783 | IXIARO 6 MCG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300783 | IXIARO 6 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300783 | IXIARO 6 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300783 | IXIARO 6 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300786 | mirabegron | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1300786 | mirabegron | Designated preferred name (PT) | YES | |
RxCUI: 1300786 | mirabegron | Full form of descriptor (FN) | YES | |
RxCUI: 1300786 | mirabegron | Designated preferred name (PT) | YES | |
RxCUI: 1300786 | mirabegron | Full form of descriptor (FN) | YES | |
RxCUI: 1300787 | mirabegron 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300788 | mirabegron Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1300788 | mirabegron Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1300788 | mirabegron Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1300789 | mirabegron Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1300790 | mirabegron Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1300791 | mirabegron 25 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300791 | mirabegron 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300791 | mirabegron 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300791 | mirabegron 25 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1300791 | mirabegron 25 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1300792 | Myrbetriq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1300793 | mirabegron 25 MG [Myrbetriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300794 | mirabegron Extended Release Oral Tablet [Myrbetriq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1300795 | Myrbetriq Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300796 | Myrbetriq Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1300797 | Myrbetriq 25 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300797 | Myrbetriq 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300797 | Myrbetriq 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300797 | Myrbetriq 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300798 | mirabegron 25 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300799 | mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300799 | mirabegron 25 MG Extended Release Oral Tablet [Myrbetriq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300800 | mirabegron 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300801 | mirabegron 50 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300801 | mirabegron 50 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300801 | mirabegron 50 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300801 | mirabegron 50 MG 24HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1300801 | mirabegron 50 MG 24HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1300802 | mirabegron 50 MG [Myrbetriq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300803 | Myrbetriq 50 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300803 | Myrbetriq 50 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300803 | Myrbetriq 50 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300803 | Myrbetriq 50 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300804 | mirabegron 50 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300805 | mirabegron 50 MG Extended Release Oral Tablet [Myrbetriq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300805 | mirabegron 50 MG Extended Release Oral Tablet [Myrbetriq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300806 | Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1300807 | Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300808 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for Hiberix) 0.5 mL Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300808 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for Hiberix) 0.5 mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300808 | Haemophilus b conjugate vaccine (tetanus toxoid conjugate) (Hib generic for Hiberix) 0.5 mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300809 | Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML [Hiberix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1300810 | HIBERIX vaccine 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1300810 | HIBERIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300810 | HIBERIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300810 | HIBERIX vaccine 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300810 | HIBERIX vaccine 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300881 | acetylcarnitine 400 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300882 | acetylcarnitine HCl 400 MG / alpha lipoic acid 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300882 | acetylcarnitine HCl 400 MG / alpha lipoic acid 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300882 | acetylcarnitine HCl 400 MG / alpha lipoic acid 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300883 | phenol 0.025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300884 | tannic acid 0.022 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1300885 | camphor / phenol / tannic acid / zinc oxide Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1300886 | camphor / phenol / tannic acid / zinc oxide Rectal Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1300887 | camphor / phenol / tannic acid / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1300888 | camphor 3 % / phenol 2.5 % / tannic acid 2.2 % / zinc oxide 6.6 % Rectal Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1300888 | camphor 3 % / phenol 2.5 % / tannic acid 2.2 % / zinc oxide 6.6 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300888 | camphor 3 % / phenol 2.5 % / tannic acid 2.2 % / zinc oxide 6.6 % Rectal Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1300888 | camphor 3 % / phenol 2.5 % / tannic acid 2.2 % / zinc oxide 6.6 % Rectal Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300889 | capsaicin 0.0375 % / menthol 5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300889 | capsaicin 0.0375 % / menthol 5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300889 | capsaicin 0.0375 % / menthol 5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300890 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1300890 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300890 | baclofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1300899 | salicylic acid Medicated Liquid Soap [Clarifoam Pure] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300900 | Clarifoam Pure Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300901 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clarifoam Pure] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300901 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clarifoam Pure] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300901 | salicylic acid 20 MG/ML Medicated Liquid Soap [Clarifoam Pure] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300902 | {1 (benzoyl peroxide 42.5 MG/ML Topical Foam) / 1 (salicylic acid 20 MG/ML Medicated Liquid Soap) / 1 (salicylic acid 20 MG/ML Topical Cream) } Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 1300903 | Clarifoam Fast | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1300904 | salicylic acid 20 MG/ML [Clarifoam Fast] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1300905 | salicylic acid Topical Cream [Clarifoam Fast] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1300906 | Clarifoam Fast Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1300907 | salicylic acid 20 MG/ML Topical Cream [Clarifoam Fast] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300907 | salicylic acid 20 MG/ML Topical Cream [Clarifoam Fast] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1300908 | BeyondClear Skin Clearing System | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
RxCUI: 1300908 | BeyondClear Skin Clearing System | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1300911 | WERA 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1300911 | WERA 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1300911 | WERA 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301015 | drospirenone 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1301016 | drospirenone 0.25 MG / ethinyl estradiol 0.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301016 | drospirenone 0.25 MG / ethinyl estradiol 0.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1301020 | krill oil 1500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301021 | krill oil 1500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301021 | krill oil 1500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301030 | Saccharomyces boulardii Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1301031 | Saccharomyces boulardii Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1301032 | Saccharomyces boulardii 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301032 | Saccharomyces boulardii 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1301032 | Saccharomyces boulardii 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301127 | triclosan 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301128 | triclosan 20 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301128 | triclosan 20 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301128 | triclosan 20 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301149 | allantoin Soap Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1301150 | allantoin Medicated Liquid Soap | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1301151 | allantoin 0.5 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301151 | allantoin 0.5 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301151 | allantoin 0.5 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301152 | benzalkonium Cl 0.13 % / benzocaine 5 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301152 | benzalkonium Cl 0.13 % / benzocaine 5 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301152 | benzalkonium Cl 0.13 % / benzocaine 5 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301159 | benzocaine 3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301159 | benzocaine 3 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301160 | benzocaine 3 MG [Cepacol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301161 | Cepacol Sensations Hydra 3 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301161 | Cepacol Sensations Hydra 3 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301161 | Cepacol Sensations Hydra 3 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301230 | benzocaine 4 MG / menthol 4 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301232 | benzocaine 4 MG / menthol 4 MG [Cepacol Sore Throat Pain Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301236 | benzocaine 4 MG / menthol 4 MG Oral Lozenge [Cepacol Sore Throat Pain Relief] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301236 | benzocaine 4 MG / menthol 4 MG Oral Lozenge [Cepacol Sore Throat Pain Relief] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301237 | benzocaine 4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301237 | benzocaine 4 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301238 | benzocaine 4 MG [Cepacol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301239 | Cepacol Sensations Warming 4 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301239 | Cepacol Sensations Warming 4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301239 | Cepacol Sensations Warming 4 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301239 | Cepacol Sensations Warming 4 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301240 | citric acid Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1301241 | citric acid Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1301242 | citric acid 0.7 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301242 | citric acid 0.7 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301242 | citric acid 0.7 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301243 | dextromethorphan / menthol Lozenge Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1301244 | dextromethorphan / menthol Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1301245 | dextromethorphan / menthol Oral Lozenge | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1301246 | dextromethorphan HBr 5 MG / menthol 5 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301246 | dextromethorphan HBr 5 MG / menthol 5 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1301255 | Ketathesia | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1301256 | ketamine 100 MG/ML [Ketathesia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301257 | ketamine Injectable Solution [Ketathesia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1301258 | Ketathesia Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1301259 | ketamine 100 MG/ML Injectable Solution [Ketathesia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301259 | ketamine 100 MG/ML Injectable Solution [Ketathesia] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301422 | menthol 0.145 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301423 | menthol 14.5 % / methyl salicylate 30 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301423 | menthol 14.5 % / methyl salicylate 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301423 | menthol 14.5 % / methyl salicylate 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301424 | Noble Lion Medicated Balm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1301425 | menthol 0.145 MG/MG / methyl salicylate 0.3 MG/MG [Noble Lion Medicated Balm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301426 | menthol / methyl salicylate Topical Ointment [Noble Lion Medicated Balm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1301427 | Noble Lion Medicated Balm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1301428 | NOBLE LION Medicated Balm 14.5 % / 30 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301428 | NOBLE LION Medicated Balm 14.5 % / 30 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301428 | NOBLE LION Medicated Balm 14.5 % / 30 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301626 | baclofen 1 MG/ML [Gablofen] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1301627 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1301627 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301627 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301627 | Gablofen 20,000 MCG in 20 ML (1,000 MCG/ML) Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301664 | Rezyst Probiotic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1301665 | Saccharomyces boulardii 250 MG [Rezyst Probiotic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1301666 | Saccharomyces boulardii Chewable Tablet [Rezyst Probiotic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1301667 | Rezyst Probiotic Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1301668 | Rezyst Probiotic Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1301669 | Rezyst Probiotic Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1301670 | ReZyst 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301670 | ReZyst 250 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301670 | ReZyst 250 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1301693 | halobetasol propionate 0.05 % Topical Cream (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1301693 | halobetasol propionate 0.05 % Topical Cream (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301694 | Ultravate X Topical Cream Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301694 | Ultravate X Topical Cream Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | NO |
RxCUI: 1301694 | Ultravate X Topical Cream Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301694 | Ultravate X Topical Cream Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301695 | halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
RxCUI: 1301695 | halobetasol propionate 0.05 % Topical Ointment (50 GM) / lactid acid 10 % Topical Cream (225 GM Pack) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301696 | Ultravate X Topical Ointment Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301696 | Ultravate X Topical Ointment Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1301696 | Ultravate X Topical Ointment Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301696 | Ultravate X Topical Ointment Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301847 | dimethicone 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1301848 | dimethicone 8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301848 | dimethicone 8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301848 | dimethicone 8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1301853 | turpentine 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301854 | white spirit type 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1301855 | white spirit type 1 950 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301856 | turpentine / white spirit type 1 Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1301857 | turpentine / white spirit type 1 Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1301858 | turpentine / white spirit type 1 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1301859 | turpentine 2 % / white spirit type 1 95 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301859 | turpentine 2 % / white spirit type 1 95 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301859 | turpentine 2 % / white spirit type 1 95 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301860 | Cornucrescine Daily Hoof Barrier | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1301861 | turpentine 20 MG/ML / white spirit type 1 950 MG/ML [Cornucrescine Daily Hoof Barrier] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301862 | turpentine / white spirit type 1 Topical Solution [Cornucrescine Daily Hoof Barrier] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1301863 | Cornucrescine Daily Hoof Barrier Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1301864 | turpentine 20 MG/ML / white spirit type 1 950 MG/ML Topical Solution [Cornucrescine Daily Hoof Barrier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301864 | turpentine 20 MG/ML / white spirit type 1 950 MG/ML Topical Solution [Cornucrescine Daily Hoof Barrier] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301866 | Lactobacillus rhamnosus GG 20 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1301866 | Lactobacillus rhamnosus GG 20 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301866 | Lactobacillus rhamnosus GG 20 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301873 | thyroid (USP) 260 MG [Nature-Throid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1301874 | Nature-Throid 260 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301874 | Nature-Throid 260 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301874 | Nature-Throid 260 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1301875 | thyroid (USP) 325 MG [Nature-Throid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1301876 | Nature-Throid 325 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301876 | Nature-Throid 325 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301876 | Nature-Throid 325 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1301881 | acetaminophen Oral Suspension [Little Fevers] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1301882 | Little Fevers 160 MG in 5 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301882 | Little Fevers 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301882 | Little Fevers 160 MG in 5 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301882 | Little Fevers 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301882 | Little Fevers 160 MG in 5 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301884 | acetaminophen 80 MG/ML Oral Suspension [Little Fevers] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301884 | acetaminophen 80 MG/ML Oral Suspension [Little Fevers] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301884 | acetaminophen 80 MG/ML Oral Suspension [Little Fevers] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301885 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1301886 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301887 | human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1301888 | human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1301889 | human papillomavirus bivalent (types 16 and 18) vaccine, recombinant 0.5 mL Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301889 | human papillomavirus bivalent (types 16 and 18) vaccine, recombinant 0.5 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301889 | human papillomavirus bivalent (types 16 and 18) vaccine, recombinant 0.5 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301890 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML [Cervarix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1301891 | CERVARIX 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301891 | CERVARIX 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1301891 | CERVARIX 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301894 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.02 MG / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.02 MG per 0.5 ML Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301894 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.02 MG / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.02 MG per 0.5 ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1301895 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301895 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1301895 | human papillomavirus type 16, L1 capsid protein (residues 2-471) vaccine 0.04 MG/ML / human papillomavirus type 18, L1 capsid protein (residues 2-472) vaccine 0.04 MG/ML Injectable Suspension [Cervarix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1301957 | sorbitol Rectal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1301958 | sorbitol Rectal Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1301959 | sorbitol 70 % Rectal Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1301959 | sorbitol 70 % Rectal Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1301959 | sorbitol 70 % Rectal Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302172 | Soothe & Cool Skin Paste | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1302173 | petrolatum 0.5 MG/MG / zinc oxide 0.1 MG/MG [Soothe & Cool Skin Paste] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302174 | petrolatum / zinc oxide Paste [Soothe & Cool Skin Paste] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302175 | Soothe & Cool Skin Paste Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302176 | Soothe & Cool Skin Paste (white petrolatum 50 % / zinc oxide 10 % ) Topical Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302176 | Soothe & Cool Skin Paste (white petrolatum 50 % / zinc oxide 10 % ) Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302176 | Soothe & Cool Skin Paste (white petrolatum 50 % / zinc oxide 10 % ) Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302176 | Soothe & Cool Skin Paste (white petrolatum 50 % / zinc oxide 10 % ) Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302180 | Fluothane | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302181 | halothane 1000 MG/ML [Fluothane] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302183 | Fluothane Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302184 | halothane 1000 MG/ML Inhalation Solution [Fluothane] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302184 | halothane 1000 MG/ML Inhalation Solution [Fluothane] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302194 | potassium chloride 1.33 MEQ | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302195 | potassium chloride 1.33 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302195 | potassium chloride 1.33 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302195 | potassium chloride 1.33 MEQ Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302195 | potassium chloride 1.33 MEQ Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302195 | potassium chloride 1.33 MEQ Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302265 | petrolatum 0.75 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302266 | petrolatum 75 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302266 | petrolatum 75 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302266 | petrolatum 75 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302274 | Doculase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1302275 | docusate sodium 100 MG [Doculase] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302276 | docusate Oral Capsule [Doculase] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302277 | Doculase Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302278 | Doculase Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302279 | Doculase 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302279 | Doculase 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302279 | Doculase 100 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302279 | Doculase 100 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302280 | docusate sodium 50 MG [Doculase] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302281 | Doculase 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302281 | Doculase 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302281 | Doculase 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302281 | Doculase 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302288 | potassium iodide 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Designated preferred name (PT) | NO | |
RxCUI: 1302289 | iodine 2.5 % / potassium iodide 2.5 % Topical Solution | Full form of descriptor (FN) | NO | |
RxCUI: 1302338 | aluminum hydroxide / magnesium hydroxide Chewable Tablet [Maalox] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302339 | Maalox Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302340 | aluminum hydroxide 200 MG / magnesium hydroxide 200 MG Chewable Tablet [Maalox] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302340 | aluminum hydroxide 200 MG / magnesium hydroxide 200 MG Chewable Tablet [Maalox] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302341 | ethanol 0.734 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302342 | ethanol 73.4 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302342 | ethanol 73.4 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302342 | ethanol 73.4 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302343 | alpha-D-galactosidase enzyme 300 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302344 | alpha-D-galactosidase enzyme Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1302345 | alpha-D-galactosidase enzyme Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1302346 | alpha-D-galactosidase 300 UNT Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302346 | alpha-D-galactosidase 300 UNT Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302350 | papain 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302351 | papain 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302351 | papain 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302353 | ferrous fumarate 18 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302353 | ferrous fumarate 18 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302361 | alpha-D-galactosidase enzyme 300 UNT [Beano] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302362 | alpha-D-galactosidase enzyme Disintegrating Oral Tablet [Beano] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302363 | Beano Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302364 | Beano 300 UNT Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302364 | Beano 300 UNT Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302364 | Beano 300 UNT Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302365 | sodium fluoride 1.1 MG [Nafrinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302366 | sodium fluoride Chewable Tablet [Nafrinse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302367 | Nafrinse Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302368 | Nafrinse 1.1 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302368 | Nafrinse 1.1 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302368 | Nafrinse 1.1 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302410 | enrofloxacin 136 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302411 | enrofloxacin Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302412 | enrofloxacin Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1302413 | enrofloxacin 136 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302413 | enrofloxacin 136 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302414 | enrofloxacin 136 MG [BAYTRIL] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302415 | enrofloxacin Chewable Tablet [BAYTRIL] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302416 | BAYTRIL Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302417 | BAYTRIL 136 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302417 | BAYTRIL 136 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302417 | BAYTRIL 136 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302418 | enrofloxacin 22.7 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302418 | enrofloxacin 22.7 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302419 | BAYTRIL 22.7 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302419 | BAYTRIL 22.7 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302419 | BAYTRIL 22.7 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302420 | enrofloxacin 68 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302420 | enrofloxacin 68 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302421 | BAYTRIL 68 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302421 | BAYTRIL 68 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302421 | BAYTRIL 68 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302422 | chlorpheniramine maleate 0.083 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302423 | guaiFENesin 2.78 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302423 | guaiFENesin 2.78 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302424 | acetaminophen / chlorpheniramine / guaifenesin Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302424 | acetaminophen / chlorpheniramine / guaifenesin Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302425 | acetaminophen / chlorpheniramine / guaifenesin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302425 | acetaminophen / chlorpheniramine / guaifenesin Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302426 | acetaminophen / chlorpheniramine / guaifenesin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1302426 | acetaminophen / chlorpheniramine / guaifenesin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302427 | acetaminophen / chlorpheniramine / guaifenesin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1302427 | acetaminophen / chlorpheniramine / guaifenesin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302428 | acetaminophen 300 MG / chlorpheniramine maleate 2.5 MG / guaiFENesin 83.3 MG in 30 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1302429 | Benzepro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1302430 | benzoyl peroxide 53 MG/ML [Benzepro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302431 | benzoyl peroxide Topical Foam [Benzepro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302432 | Benzepro Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302433 | BenzePrO 5.3 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302433 | BenzePrO 5.3 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302433 | BenzePrO 5.3 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302436 | benzoyl peroxide 98 MG/ML [Benzepro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302437 | BenzePrO Short Contact 9.8 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302437 | BenzePrO Short Contact 9.8 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302437 | BenzePrO Short Contact 9.8 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302449 | Lactobacillus acidophilus 500 Million UNT Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302449 | Lactobacillus acidophilus 500 Million UNT Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302450 | omega-3 acid ethyl esters (USP) 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302451 | omega-3 acid ethyl esters (USP) / salmon oil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302452 | omega-3 acid ethyl esters (USP) / salmon oil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302453 | omega-3 acid ethyl esters (USP) / salmon oil Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1302454 | omega-3 acid ethyl esters (USP) / salmon oil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1302455 | omega-3 acid ethyl esters (USP) 200 MG / salmon oil 1000 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302459 | inulin 245 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302464 | Lactobacillus rhamnosus GG 10 billion cell / inulin 245 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302464 | Lactobacillus rhamnosus GG 10 billion cell / inulin 245 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302472 | Lactobacillus reuteri 2.5 Billion UNT / Lactobacillus rhamnosus GG 2.5 Billion UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302472 | Lactobacillus reuteri 2.5 Billion UNT / Lactobacillus rhamnosus GG 2.5 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302474 | sodium fluoride 2.2 MG [Nafrinse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302475 | Nafrinse 2.2 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302475 | Nafrinse 2.2 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302475 | Nafrinse 2.2 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302481 | citric acid / gluconolactone / magnesium carbonate Irrigation Solution [Renacidin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302482 | Renacidin Irrigation Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302483 | RENACIDIN 6.602 GM / 0.198 GM / 3.376 GM per 100 mL Irrigation Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302483 | RENACIDIN 6.602 GM / 0.198 GM / 3.376 GM per 100 mL Irrigation Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302483 | RENACIDIN 6.602 GM / 0.198 GM / 3.376 GM per 100 mL Irrigation Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302615 | benzethonium Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1302616 | benzethonium Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1302617 | benzethonium chloride 0.2 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302617 | benzethonium chloride 0.2 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302617 | benzethonium chloride 0.2 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302623 | Qore-24 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302624 | benzalkonium chloride 1 MG/ML [Qore-24] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302625 | benzalkonium Topical Spray [Qore-24] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302626 | Qore-24 Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302627 | Qore-24 0.1 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302627 | Qore-24 0.1 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302627 | Qore-24 0.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302627 | Qore-24 0.1 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302628 | urea 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302628 | urea 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302629 | benzyl alcohol / camphor / menthol Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1302630 | benzyl alcohol 10 % / camphor 0.5 % / menthol 0.25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302630 | benzyl alcohol 10 % / camphor 0.5 % / menthol 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302630 | benzyl alcohol 10 % / camphor 0.5 % / menthol 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302631 | benzyl alcohol 0.1 ML/ML / camphor 5 MG/ML / menthol 2.5 MG/ML [Ivy Dry Super Continuous Spray] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302632 | benzyl alcohol / camphor / menthol Topical Spray [Ivy Dry Super Continuous Spray] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302633 | IVY DRY SUPER 10 % / 0.5 % / 0.25 % Topical Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302633 | IVY DRY SUPER 10 % / 0.5 % / 0.25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302633 | IVY DRY SUPER 10 % / 0.5 % / 0.25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302635 | calcium carbonate 118 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302636 | calcium 47 MG / dehydroepiandrosterone 10 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302636 | calcium 47 MG / dehydroepiandrosterone 10 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302636 | calcium 47 MG / dehydroepiandrosterone 10 MG Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302637 | calcium 60 MG / dehydroepiandrosterone 50 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302637 | calcium 60 MG / dehydroepiandrosterone 50 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302637 | calcium 60 MG / dehydroepiandrosterone 50 MG Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302638 | calcium carbonate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302639 | calcium 52 MG / dehydroepiandrosterone 25 MG Oral Tablet, as calcium carbonate | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302639 | calcium 52 MG / dehydroepiandrosterone 25 MG Oral Tablet, as calcium carbonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302639 | calcium 52 MG / dehydroepiandrosterone 25 MG Oral Tablet, as calcium carbonate | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302640 | salicylic acid Medicated Pad [Propa P.H.] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302641 | Propa P.H. Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302642 | Propa P.H. Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302643 | salicylic acid 20 MG/ML Medicated Pad [Propa P.H.] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302643 | salicylic acid 20 MG/ML Medicated Pad [Propa P.H.] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302643 | salicylic acid 20 MG/ML Medicated Pad [Propa P.H.] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302650 | minocycline HCl 45 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302650 | minocycline HCl 45 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302650 | minocycline HCl 45 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302651 | Ximino | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1302652 | minocycline 45 MG [Ximino] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302653 | minocycline Extended Release Oral Capsule [Ximino] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302654 | Ximino Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302655 | Ximino Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302656 | Ximino 45 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302656 | Ximino 45 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302656 | Ximino 45 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302657 | minocycline 45 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302657 | minocycline 45 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302658 | minocycline 67.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302659 | minocycline HCl 67.5 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302659 | minocycline HCl 67.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302659 | minocycline HCl 67.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302660 | minocycline 67.5 MG [Ximino] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302661 | 24 HR minocycline 67.5 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302661 | 24 HR minocycline 67.5 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302662 | minocycline 67.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302663 | minocycline 67.5 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302663 | minocycline 67.5 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302664 | minocycline HCl 90 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302664 | minocycline HCl 90 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302664 | minocycline HCl 90 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302665 | minocycline 90 MG [Ximino] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302666 | Ximino 90 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302666 | Ximino 90 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302666 | Ximino 90 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302667 | minocycline 90 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302667 | minocycline 90 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302668 | minocycline 112.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302669 | minocycline HCl 112.5 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302669 | minocycline HCl 112.5 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302669 | minocycline HCl 112.5 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302670 | minocycline 112.5 MG [Ximino] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302671 | 24 HR minocycline 112.5 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302671 | 24 HR minocycline 112.5 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302671 | 24 HR minocycline 112.5 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302672 | minocycline 112.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302673 | minocycline 112.5 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302673 | minocycline 112.5 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302674 | minocycline HCl 135 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302674 | minocycline HCl 135 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302674 | minocycline HCl 135 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302675 | minocycline 135 MG [Ximino] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302676 | Ximino 135 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302676 | Ximino 135 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302676 | Ximino 135 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302677 | minocycline 135 MG Extended Release Oral Capsule [Ximino] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302677 | minocycline 135 MG Extended Release Oral Capsule [Ximino] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302678 | cholecalciferol / vitamin A Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1302679 | cholecalciferol / vitamin A Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1302680 | vitamin A 4000 UNT / vitamin D3 400 UNT in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302680 | vitamin A 4000 UNT / vitamin D3 400 UNT in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302680 | vitamin A 4000 UNT / vitamin D3 400 UNT in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302681 | magnesium sulfate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302682 | alpha-tocopherol succinate 200 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302683 | zinc sulfate 18 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302684 | alpha-Tocopherol Succinate 200 UNT / vit-C 100 MG / Magnesium Sulfate 10 MG / ZnSO4 18 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302684 | alpha-Tocopherol Succinate 200 UNT / vit-C 100 MG / Magnesium Sulfate 10 MG / ZnSO4 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302684 | alpha-Tocopherol Succinate 200 UNT / vit-C 100 MG / Magnesium Sulfate 10 MG / ZnSO4 18 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302685 | tocotrienols 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302686 | vitamin E 50 UNT / tocotrienols 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302686 | vitamin E 50 UNT / tocotrienols 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302737 | benzethonium chloride 0.13 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302737 | benzethonium chloride 0.13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302737 | benzethonium chloride 0.13 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302738 | butorphanol 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302739 | butorphanol 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302739 | butorphanol 10 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302740 | butorphanol 10 MG/ML [Dolorex Solution] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302741 | butorphanol 10 MG/ML Injectable Solution [Dolorex Solution] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302741 | butorphanol 10 MG/ML Injectable Solution [Dolorex Solution] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302741 | butorphanol 10 MG/ML Injectable Solution [Dolorex Solution] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302745 | dimethicone Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1302746 | dimethicone 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302746 | dimethicone 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302746 | dimethicone 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302747 | Footlogix Moisturizing Diabetic Formula | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302748 | dimethicone 10 MG/ML [Footlogix Moisturizing Diabetic Formula] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302749 | dimethicone Topical Foam [Footlogix Moisturizing Diabetic Formula] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302750 | Footlogix Moisturizing Diabetic Formula Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302751 | footlogix Moisturizing Diabetic Formula 1 % Topical Foam | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302751 | footlogix Moisturizing Diabetic Formula 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302751 | footlogix Moisturizing Diabetic Formula 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302751 | footlogix Moisturizing Diabetic Formula 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302755 | VELETRI 0.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302755 | VELETRI 0.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302755 | VELETRI 0.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302765 | methyl salicylate 0.183 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1302766 | menthol 16 % / methyl salicylate 18.3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302766 | menthol 16 % / methyl salicylate 18.3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302766 | menthol 16 % / methyl salicylate 18.3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302796 | Bayer Migraine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302797 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Bayer Migraine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302798 | acetaminophen / aspirin / caffeine Oral Tablet [Bayer Migraine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302799 | Bayer Migraine Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302800 | Bayer Migraine Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302801 | BAYER Migraine Formula 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302801 | BAYER Migraine Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302801 | BAYER Migraine Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302801 | BAYER Migraine Formula 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302821 | phentermine 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302822 | topiramate 46 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302823 | phentermine / topiramate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1302824 | phentermine / topiramate Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1302825 | phentermine / topiramate Extended Release Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1302826 | phentermine / topiramate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1302827 | phentermine 7.5 MG / topiramate 46 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302827 | phentermine 7.5 MG / topiramate 46 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302827 | phentermine 7.5 MG / topiramate 46 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302829 | phentermine 7.5 MG / topiramate 46 MG [Qsymia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302830 | phentermine / topiramate Extended Release Oral Capsule [Qsymia] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1302831 | Qsymia Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302832 | Qsymia Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1302833 | Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302833 | Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302833 | Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302833 | Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302833 | Qsymia 7.5 MG / 46 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302834 | phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302835 | phentermine 7.5 MG / topiramate 46 MG Extended Release Oral Capsule [Qsymia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302837 | phentermine 3.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302838 | topiramate 23 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302839 | phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302839 | phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302839 | phentermine 3.75 MG / topiramate 23 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302841 | phentermine 3.75 MG / topiramate 23 MG [Qsymia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302845 | Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302845 | Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302845 | Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302845 | Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302845 | Qsymia 3.75 MG / 23 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302846 | phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302847 | phentermine 3.75 MG / topiramate 23 MG Extended Release Oral Capsule [Qsymia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302848 | phentermine 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302849 | topiramate 92 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302850 | phentermine 15 MG / topiramate 92 MG 24HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1302850 | phentermine 15 MG / topiramate 92 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302850 | phentermine 15 MG / topiramate 92 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302852 | phentermine 15 MG / topiramate 92 MG [Qsymia] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1302856 | Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1302856 | Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1302856 | Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302856 | Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302856 | Qsymia 15 MG / 92 MG 24HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1302857 | phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302858 | phentermine 15 MG / topiramate 92 MG Extended Release Oral Capsule [Qsymia] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302860 | topiramate 69 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1302897 | benzoyl peroxide 10 % Medicated Liquid Soap (118 ML) / salicylic acid 2 % Topical Gel (15 ML) / salicyclic acid 2 % Topical Lotion (59 ML) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
RxCUI: 1302897 | benzoyl peroxide 10 % Medicated Liquid Soap (118 ML) / salicylic acid 2 % Topical Gel (15 ML) / salicyclic acid 2 % Topical Lotion (59 ML) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302906 | petrolatum 99.9 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1302906 | petrolatum 99.9 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302906 | petrolatum 99.9 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302907 | Luvena Feminine Wipes | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302908 | pramoxine hydrochloride 10 MG/ML [Luvena Feminine Wipes] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1302909 | pramoxine Medicated Pad [Luvena Feminine Wipes] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302910 | Luvena Feminine Wipes Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302911 | Luvena Feminine Wipes Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302912 | Luvena Feminine 1 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1302912 | Luvena Feminine 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302912 | Luvena Feminine 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1302912 | Luvena Feminine 1 % Medicated Pad | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1302939 | Atopalm Hemorrhoidal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1302941 | mineral oil / petrolatum / phenylephrine Rectal Ointment [Atopalm Hemorrhoidal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1302942 | Atopalm Hemorrhoidal Rectal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1302966 | carfilzomib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1302966 | carfilzomib | Designated preferred name (PT) | YES | |
RxCUI: 1302966 | carfilzomib | Full form of descriptor (FN) | YES | |
RxCUI: 1302966 | carfilzomib | Designated preferred name (PT) | YES | |
RxCUI: 1302966 | carfilzomib | Full form of descriptor (FN) | YES | |
RxCUI: 1302968 | carfilzomib Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1302968 | carfilzomib Injectable Product | Designated preferred name (PT) | YES | |
RxCUI: 1302968 | carfilzomib Injectable Product | Full form of descriptor (FN) | YES | |
RxCUI: 1302971 | Kyprolis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1302974 | Kyprolis Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303097 | aclidinium bromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1303097 | aclidinium bromide | Designated preferred name (PT) | YES | |
RxCUI: 1303097 | aclidinium bromide | Full form of descriptor (FN) | YES | |
RxCUI: 1303098 | aclidinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1303098 | aclidinium | Designated preferred name (PT) | YES | |
RxCUI: 1303098 | aclidinium | Full form of descriptor (FN) | YES | |
RxCUI: 1303098 | aclidinium | Designated preferred name (PT) | YES | |
RxCUI: 1303098 | aclidinium | Full form of descriptor (FN) | YES | |
RxCUI: 1303099 | aclidinium bromide 0.4 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303100 | aclidinium Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1303100 | aclidinium Inhalant Product | Designated preferred name (PT) | YES | |
RxCUI: 1303100 | aclidinium Inhalant Product | Full form of descriptor (FN) | YES | |
RxCUI: 1303101 | aclidinium Dry Powder Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1303102 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303102 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303102 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303102 | aclidinium bromide 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303103 | Tudorza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303104 | aclidinium bromide 0.4 MG/ACTUAT [Tudorza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303105 | aclidinium Dry Powder Inhaler [Tudorza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303106 | Tudorza Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303107 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303107 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303107 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303107 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303107 | Tudorza Pressair 400 MCG/INHAL Dry Powder Inhaler, 60 ACTUAT | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303110 | benzalkonium Cl 0.11 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303110 | benzalkonium Cl 0.11 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303110 | benzalkonium Cl 0.11 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303112 | benzalkonium / lidocaine Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1303113 | benzalkonium / lidocaine Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1303114 | benzalkonium chloride 0.1 % / lidocaine hydrochloride 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303114 | benzalkonium chloride 0.1 % / lidocaine hydrochloride 1 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303114 | benzalkonium chloride 0.1 % / lidocaine hydrochloride 1 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303124 | predniSONE Delayed Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1303124 | predniSONE Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303125 | predniSONE 1 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303125 | predniSONE 1 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303125 | predniSONE 1 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303126 | Rayos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303127 | predniSONE 1 MG [Rayos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303127 | predniSONE 1 MG [Rayos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303128 | predniSONE Delayed Release Oral Tablet [Rayos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303128 | predniSONE Delayed Release Oral Tablet [Rayos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303129 | Rayos Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303130 | Rayos Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303131 | Rayos 1 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303131 | Rayos 1 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303131 | Rayos 1 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303131 | Rayos 1 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303132 | predniSONE 2 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303132 | predniSONE 2 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303132 | predniSONE 2 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303133 | predniSONE 2 MG [Rayos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303133 | predniSONE 2 MG [Rayos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303134 | Rayos 2 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303134 | Rayos 2 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303134 | Rayos 2 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303134 | Rayos 2 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303135 | predniSONE 5 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303135 | predniSONE 5 MG Delayed Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303135 | predniSONE 5 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303136 | predniSONE 5 MG [Rayos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303136 | predniSONE 5 MG [Rayos] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303137 | Rayos 5 MG Delayed Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303137 | Rayos 5 MG Delayed Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303137 | Rayos 5 MG Delayed Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303137 | Rayos 5 MG Delayed Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303154 | Arthriten Inflammatory Pain | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303155 | acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG [Arthriten Inflammatory Pain] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303156 | acetaminophen / aspirin / caffeine Oral Tablet [Arthriten Inflammatory Pain] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303157 | Arthriten Inflammatory Pain Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303158 | Arthriten Inflammatory Pain Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303159 | ARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303159 | ARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303159 | ARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303159 | ARTHRITEN Inflammatory Pain Formula 250 MG / 250 MG / 65 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303160 | petrolatum 0.929 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303161 | petrolatum 929.3 MG per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303161 | petrolatum 929.3 MG per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303161 | petrolatum 929.3 MG per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303247 | acetaminophen / caffeine / chlorpheniramine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1303248 | acetaminophen / caffeine / chlorpheniramine Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1303249 | acetaminophen / caffeine / chlorpheniramine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1303250 | acetaminophen / caffeine / chlorpheniramine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1303251 | acetaminophen 100 MG / caffeine 2 MG / chlorpheniramine maleate 2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303251 | acetaminophen 100 MG / caffeine 2 MG / chlorpheniramine maleate 2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303251 | acetaminophen 100 MG / caffeine 2 MG / chlorpheniramine maleate 2 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303317 | corn starch 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303318 | lanolin 155 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303319 | zinc oxide 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303320 | corn starch / lanolin / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1303321 | corn starch / lanolin / zinc oxide Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1303322 | corn starch / lanolin / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1303323 | corn starch 250 MG/ML / Lanolin 155 MG/ML / ZNO 300 MG/ML Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303323 | corn starch 250 MG/ML / Lanolin 155 MG/ML / ZNO 300 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303323 | corn starch 250 MG/ML / Lanolin 155 MG/ML / ZNO 300 MG/ML Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303324 | undecylenic acid 250 MG/ML [Hongo Killer Treatment] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303325 | Hongo Killer Treatment 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303325 | Hongo Killer Treatment 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303325 | Hongo Killer Treatment 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303325 | Hongo Killer Treatment 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303326 | Baby Butz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1303327 | corn starch 250 MG/ML / lanolin 155 MG/ML / zinc oxide 300 MG/ML [Baby Butz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303328 | corn starch / lanolin / zinc oxide Topical Cream [Baby Butz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1303329 | Baby Butz Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1303330 | corn starch 250 MG/ML / lanolin 155 MG/ML / zinc oxide 300 MG/ML Topical Cream [Baby Butz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303330 | corn starch 250 MG/ML / lanolin 155 MG/ML / zinc oxide 300 MG/ML Topical Cream [Baby Butz] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303330 | corn starch 250 MG/ML / lanolin 155 MG/ML / zinc oxide 300 MG/ML Topical Cream [Baby Butz] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303354 | Denorex Extra Strength Reformulated Aug 2012 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303355 | salicylic acid 30 MG/ML [Denorex Extra Strength Reformulated Aug 2012] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303356 | salicylic acid Medicated Shampoo [Denorex Extra Strength Reformulated Aug 2012] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303357 | Denorex Extra Strength Reformulated Aug 2012 Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303358 | Denorex Extra Strength 3 % Medicated Shampoo, Reformulated Aug 2012 | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303358 | Denorex Extra Strength 3 % Medicated Shampoo, Reformulated Aug 2012 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303358 | Denorex Extra Strength 3 % Medicated Shampoo, Reformulated Aug 2012 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303358 | Denorex Extra Strength 3 % Medicated Shampoo, Reformulated Aug 2012 | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303583 | dexchlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303583 | dexchlorpheniramine maleate 4 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303584 | Dexchlorpheniramine maleate 4 MG / Pseudoephedrine Hydrochloride 60 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303584 | Dexchlorpheniramine maleate 4 MG / Pseudoephedrine Hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303705 | Factor VIII specific immunoglobulin E | Designated preferred name (PT) | NO | |
RxCUI: 1303705 | Factor VIII specific immunoglobulin E | Full form of descriptor (FN) | NO | |
RxCUI: 1303708 | HLA-B3 antigen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303708 | HLA-B3 antigen | Designated preferred name (PT) | NO | |
RxCUI: 1303708 | HLA-B3 antigen | Full form of descriptor (FN) | NO | |
RxCUI: 1303713 | Lymphocyte antigen CD41a | Designated preferred name (PT) | NO | |
RxCUI: 1303713 | Lymphocyte antigen CD41a | Full form of descriptor (FN) | NO | |
RxCUI: 1303714 | Lymphocyte antigen CD65L | Designated preferred name (PT) | NO | |
RxCUI: 1303714 | Lymphocyte antigen CD65L | Full form of descriptor (FN) | NO | |
RxCUI: 1303716 | Thiopentone specific immunoglobulin E | Designated preferred name (PT) | NO | |
RxCUI: 1303716 | Thiopentone specific immunoglobulin E | Full form of descriptor (FN) | NO | |
RxCUI: 1303716 | Thiopentone specific immunoglobulin E | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303724 | bacitracin / pramoxine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1303725 | bacitracin / pramoxine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1303726 | bacitracin / pramoxine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1303727 | bacitracin 500 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303727 | bacitracin 500 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303727 | bacitracin 500 UNT / pramoxine HCl 10 MG per GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303728 | morphine sulfate 130 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303729 | morphine sulfate 130 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303729 | morphine sulfate 130 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303729 | morphine sulfate 130 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303730 | morphine sulfate 130 MG [Kadian] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303731 | KADIAN 130 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303731 | KADIAN 130 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303731 | KADIAN 130 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303731 | KADIAN 130 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303732 | morphine sulfate 150 MG [Kadian] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303733 | KADIAN 150 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303733 | KADIAN 150 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303733 | KADIAN 150 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303733 | KADIAN 150 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303734 | capsaicin 0.15 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303734 | capsaicin 0.15 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303734 | capsaicin 0.15 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303735 | morphine sulfate 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303736 | morphine sulfate 40 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303736 | morphine sulfate 40 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303736 | morphine sulfate 40 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303737 | morphine sulfate 40 MG [Kadian] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303738 | KADIAN 40 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303738 | KADIAN 40 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303738 | KADIAN 40 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303738 | KADIAN 40 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303739 | morphine sulfate 70 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303740 | morphine sulfate 70 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303740 | morphine sulfate 70 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303740 | morphine sulfate 70 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303741 | morphine sulfate 70 MG [Kadian] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303742 | KADIAN 70 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303742 | KADIAN 70 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303742 | KADIAN 70 MG Extended Release Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303742 | KADIAN 70 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303745 | levOCARNitine 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303745 | levOCARNitine 20 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303746 | coenzyme Q10 100 MG / levOCARNitine 20 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303746 | coenzyme Q10 100 MG / levOCARNitine 20 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303746 | coenzyme Q10 100 MG / levOCARNitine 20 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1303770 | menthol 9 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303771 | benzocaine 4 MG / menthol 9 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303771 | benzocaine 4 MG / menthol 9 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303772 | Cepacol Sensations Cooling | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1303773 | benzocaine 4 MG / menthol 9 MG [Cepacol Sensations Cooling] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1303774 | benzocaine / menthol Oral Lozenge [Cepacol Sensations Cooling] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1303775 | Cepacol Sensations Cooling Lozenge Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1303776 | Cepacol Sensations Cooling Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1303777 | Cepacol Sensations Cooling 4 MG / 9 MG Oral Lozenge | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1303777 | Cepacol Sensations Cooling 4 MG / 9 MG Oral Lozenge | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303777 | Cepacol Sensations Cooling 4 MG / 9 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303795 | dexbrompheniramine maleate 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303796 | dextromethorphan hydrobromide 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303797 | dexbrompheniramine maleate 1 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303797 | dexbrompheniramine maleate 1 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303797 | dexbrompheniramine maleate 1 MG / dextromethorphan HBr 10 MG / phenylephrine HCl 5 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303807 | melatonin 10 MG / pyridoxine HCl 10 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303807 | melatonin 10 MG / pyridoxine HCl 10 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303807 | melatonin 10 MG / pyridoxine HCl 10 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303808 | omega-3 acid ethyl esters 500 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303808 | omega-3 acid ethyl esters 500 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303834 | homatropine / HYDROcodone Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1303834 | homatropine / HYDROcodone Injectable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303835 | homatropine / HYDROcodone Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1303835 | homatropine / HYDROcodone Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303836 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303836 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303836 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303836 | homatropine methylbromide 1.5 MG / hydrocodone bitartrate 5 MG per 5 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303837 | mecobalamin 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303838 | mecobalamin Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1303839 | mecobalamin Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1303840 | mecobalamin 5000 MCG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303840 | mecobalamin 5000 MCG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303840 | mecobalamin 5000 MCG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303843 | chlophedianol hydrochloride 1.67 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303844 | phenylephrine hydrochloride 0.667 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303845 | chlophedianol hydrochloride 1.67 MG/mL / guaiFENesin 13.3 MG/mL / phenylephrine hydrochloride 0.667 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1303845 | chlophedianol hydrochloride 1.67 MG/mL / guaiFENesin 13.3 MG/mL / phenylephrine hydrochloride 0.667 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303845 | chlophedianol hydrochloride 1.67 MG/mL / guaiFENesin 13.3 MG/mL / phenylephrine hydrochloride 0.667 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303845 | chlophedianol hydrochloride 1.67 MG/mL / guaiFENesin 13.3 MG/mL / phenylephrine hydrochloride 0.667 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303845 | chlophedianol hydrochloride 1.67 MG/mL / guaiFENesin 13.3 MG/mL / phenylephrine hydrochloride 0.667 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1303875 | trichloroacetic acid 1000 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303876 | trichloroacetic acid 100 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303876 | trichloroacetic acid 100 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303876 | trichloroacetic acid 100 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303877 | trichloroacetic acid 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303878 | trichloroacetic acid 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303878 | trichloroacetic acid 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303878 | trichloroacetic acid 20 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303881 | trichloroacetic acid 250 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303882 | trichloroacetic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303882 | trichloroacetic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303882 | trichloroacetic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303885 | trichloroacetic acid 700 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1303886 | trichloroacetic acid 70 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1303886 | trichloroacetic acid 70 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1303887 | trichloroacetic acid 750 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303888 | trichloroacetic acid 75 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303888 | trichloroacetic acid 75 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303888 | trichloroacetic acid 75 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303889 | trichloroacetic acid 850 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1303890 | trichloroacetic acid 85 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303890 | trichloroacetic acid 85 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303890 | trichloroacetic acid 85 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1303911 | Dialyvite Vitamin D3 Max | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303913 | cholecalciferol Oral Tablet [Dialyvite Vitamin D3 Max] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303914 | Dialyvite Vitamin D3 Max Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303915 | Dialyvite Vitamin D3 Max Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303916 | Dialyvite Vitamin D3 Max 1250 MCG (50,000 UNT) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303916 | Dialyvite Vitamin D3 Max 1250 MCG (50,000 UNT) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303916 | Dialyvite Vitamin D3 Max 1250 MCG (50,000 UNT) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1303916 | Dialyvite Vitamin D3 Max 1250 MCG (50,000 UNT) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303925 | Next Choice One Dose | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1303926 | levonorgestrel 1.5 MG [Next Choice One Dose] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1303927 | levonorgestrel Oral Tablet [Next Choice One Dose] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1303928 | Next Choice One Dose Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303929 | Next Choice One Dose Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1303930 | Next Choice ONE DOSE Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1303930 | Next Choice ONE DOSE Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1303930 | Next Choice ONE DOSE Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304 | Bacterial protein | Designated preferred name (PT) | NO | |
RxCUI: 1304 | Bacterial protein | Full form of descriptor (FN) | NO | |
RxCUI: 1304072 | acetaminophen 105 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304073 | chlorpheniramine maleate 1.05 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304074 | chlorpheniramine maleate 1.05 MG / acetaminophen 105 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304074 | chlorpheniramine maleate 1.05 MG / acetaminophen 105 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304074 | chlorpheniramine maleate 1.05 MG / acetaminophen 105 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304076 | camphor 21.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304077 | menthol 14.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304078 | methyl salicylate 64.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304079 | camphor 21.21 MG / menthol 14.14 MG / methyl salicylate 64.45 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304079 | camphor 21.21 MG / menthol 14.14 MG / methyl salicylate 64.45 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304079 | camphor 21.21 MG / menthol 14.14 MG / methyl salicylate 64.45 MG Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304082 | camphor 43.8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304083 | menthol 37 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304084 | methyl salicylate 72.4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304085 | camphor 43.76 MG / menthol 37.02 MG / methyl salicylate 72.39 MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304085 | camphor 43.76 MG / menthol 37.02 MG / methyl salicylate 72.39 MG Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304085 | camphor 43.76 MG / menthol 37.02 MG / methyl salicylate 72.39 MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304093 | Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1304093 | Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product) | Designated preferred name (PT) | YES | |
RxCUI: 1304093 | Product containing citric acid and magnesium oxide and sodium picosulfate (medicinal product) | Full form of descriptor (FN) | YES | |
RxCUI: 1304095 | Prepopik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1304099 | Prepopik Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304105 | brompheniramine maleate 4 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304105 | brompheniramine maleate 4 MG / dextromethorphan HBr 20 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304108 | dextromethorphan hydrobromide 7.5 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304108 | dextromethorphan hydrobromide 7.5 MG / pseudoephedrine HCl 15 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304111 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304111 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304111 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304214 | aspirin / caffeine Oral Tablet [Bayer Headache Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304215 | BAYER Headache Relief 500 MG / 32.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304215 | BAYER Headache Relief 500 MG / 32.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304215 | BAYER Headache Relief 500 MG / 32.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304215 | BAYER Headache Relief 500 MG / 32.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304248 | Duraflor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304249 | sodium fluoride 50 MG/ML [Duraflor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304250 | sodium fluoride Mouthwash [Duraflor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304251 | Duraflor Dental Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304252 | Duraflor Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304253 | Duraflor Mouthwash Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304254 | Duraflor 5 % Dental Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304254 | Duraflor 5 % Dental Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304254 | Duraflor 5 % Dental Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304254 | Duraflor 5 % Dental Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304288 | Tisseel Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304375 | Denorex Therapeutic | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1304376 | coal tar 25 MG/ML [Denorex Therapeutic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304377 | coal tar Medicated Shampoo [Denorex Therapeutic] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1304378 | Denorex Therapeutic Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304379 | coal tar 25 MG/ML Medicated Shampoo [Denorex Therapeutic] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304379 | coal tar 25 MG/ML Medicated Shampoo [Denorex Therapeutic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304379 | coal tar 25 MG/ML Medicated Shampoo [Denorex Therapeutic] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304404 | Bioflexor | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304405 | menthol 0.03 MG/MG [Bioflexor] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304406 | menthol Topical Gel [Bioflexor] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304407 | Bioflexor Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304408 | BioFlexor 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304408 | BioFlexor 3 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304408 | BioFlexor 3 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304408 | BioFlexor 3 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304464 | Artiss Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304470 | nonoxynol-9 150 MG [Conceptrol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304472 | nonoxynol-9 150 MG Vaginal Insert [Conceptrol] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304472 | nonoxynol-9 150 MG Vaginal Insert [Conceptrol] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304475 | ziv-aflibercept | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1304476 | ziv-aflibercept 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304480 | Zaltrap | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304481 | ziv-aflibercept 25 MG/ML [Zaltrap] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304483 | Zaltrap Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304485 | nonoxynol-9 0.03 MG/MG [Ramses Personal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304486 | nonoxynol-9 Vaginal Gel [Ramses Personal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1304487 | Ramses Personal Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304488 | nonoxynol-9 0.03 MG/MG Vaginal Gel [Ramses Personal] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304488 | nonoxynol-9 0.03 MG/MG Vaginal Gel [Ramses Personal] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304489 | iron carbonyl 35 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304490 | alpha-Tocopherol Acetate 30 UNT / vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / Cupric oxide 2 MG / DOSS Sodium 50 MG / folate 1 MG / Iron Carbonyl 35 MG / Niacinamide 20 MG / K+ Iodide 0.15 MG / vit-B6 Hydrochloride 25 MG / Riboflavin 3.4 MG / vitamin B1 hydrochloride 3 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304491 | alpha-tocopherol acetate 11 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304492 | iron carbonyl 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304493 | alpha tocopherol / ascorbic acid / cholecalciferol / folic acid / iron carbonyl / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1304494 | alpha tocopherol / ascorbic acid / cholecalciferol / folic acid / iron carbonyl / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1304495 | alpha tocopherol / ascorbic acid / cholecalciferol / folic acid / iron carbonyl / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1304496 | alpha tocopherol / ascorbic acid / cholecalciferol / folic acid / iron carbonyl / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304497 | alpha-tocopherol acetate 11 UNT / vitamin C 120 MG / cholecalciferol 400 UNT / folate 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / vitamin B6 hydrochloride 10 MG / riboflavin 3 MG / vitamin B1 mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304498 | Natafort | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1304499 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG [Natafort] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304500 | alpha tocopherol / ascorbic acid / cholecalciferol / folic acid / iron carbonyl / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 Oral Tablet [Natafort] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1304501 | Natafort Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304502 | Natafort Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304503 | alpha-tocopherol acetate 11 UNT / ascorbic acid 120 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 60 MG / niacinamide 20 MG / pyridoxine hydrochloride 10 MG / riboflavin 3 MG / thiamine mononitrate 2 MG / vitamin B12 0.012 MG Oral Tablet [Natafort] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304505 | salmon oil 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304506 | salmon oil 500 MG / omega-3 acid ethyl esters 100 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304506 | salmon oil 500 MG / omega-3 acid ethyl esters 100 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304507 | alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1304508 | alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1304509 | alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1304510 | alpha tocopherol / ascorbic acid / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin B12 / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304511 | alpha-tocopherol acetate 30 UNT / vitamin C 120 MG / calcium carbonate 200 MG / cholecalciferol 400 UNT / cupric oxide 2 MG / DOSS sodium 50 MG / folate 1 MG / iron carbonyl 90 MG / magnesium oxide 30 MG / niacinamide 20 MG / vitamin B6 hydrochloride 20 MG / riboflavin 3.4 MG / vit-B1 mononitrate 3 MG / vitamin B12 0.012 MG / ZNO 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304531 | brompheniramine tannate 1.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304532 | pseudoephedrine tannate 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304533 | brompheniramine tannate 6 MG / pseudoephedrine tannate 30 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304533 | brompheniramine tannate 6 MG / pseudoephedrine tannate 30 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304545 | alpha-tocopherol acetate 1 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304546 | biotin 0.006 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304547 | cholecalciferol 20 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304548 | dexpanthenol 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304549 | niacinamide 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304550 | pyridoxine hydrochloride 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304551 | vitamin A palmitate 330 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304552 | riboflavin 0.36 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304553 | thiamine hydrochloride 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304554 | vitamin B12 0.0005 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304555 | vitamin K1 0.015 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304556 | alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1304557 | alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1304558 | alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304559 | alpha-tocopherol acetate 1 UNT/ML / vitamin C 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folate 0.06 MG/ML / niacinamide 4 MG/ML / vit-B6 hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / vitamin B1 hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304560 | Infuvite | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304561 | alpha-tocopherol acetate 1 UNT/ML / ascorbic acid 20 MG/ML / biotin 0.006 MG/ML / cholecalciferol 20 UNT/ML / dexpanthenol 1.5 MG/ML / folic acid 0.06 MG/ML / niacinamide 4 MG/ML / pyridoxine hydrochloride 0.6 MG/ML / riboflavin 0.36 MG/ML / thiamine hydrochloride 0.6 MG/ML / vitamin A palmitate 330 UNT/ML / vitamin B12 0.0005 MG/ML / vitamin K1 0.015 MG/ML [Infuvite] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304562 | alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Solution [Infuvite] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304563 | Infuvite Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304564 | Infuvite Adult (alpha-tocopherol acetate 10 UNT / ascorbic acid 200 MG / biotin 60 MCG / cholecalciferol 200 UNT / cyanocobalmin 5 MCG / dexpanthenol 15 MG / folic acid 600 MCG / niacinamide 40 MG / phytonadione 150 MCG / pyridoxine hydrochloride 6 MG / riboflavin 3.6 MG / thiamine hydrochloride 6 MG / vitamin A palmitate 3300 UNT) per 10 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304565 | coal tar 20 MG/ML / salicylic acid 40 MG/ML [X-Seb T Pearl] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304566 | X-Seb T Pearl 10 % / 4 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304566 | X-Seb T Pearl 10 % / 4 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304566 | X-Seb T Pearl 10 % / 4 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304567 | coal tar 25 MG/ML [Denorex Extra Strength] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304568 | coal tar 25 MG/ML Medicated Shampoo [Denorex Extra Strength] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304568 | coal tar 25 MG/ML Medicated Shampoo [Denorex Extra Strength] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304568 | coal tar 25 MG/ML Medicated Shampoo [Denorex Extra Strength] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304570 | cholecalciferol 170 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304571 | docosahexaenoic acid 265 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304572 | ferrous fumarate 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304573 | folic acid 1.24 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304580 | menthol 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304580 | menthol 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304580 | menthol 5 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304581 | Banadyne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1304582 | menthol 50 MG/ML [Banadyne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304583 | menthol Topical Solution [Banadyne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1304584 | Banadyne Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304585 | Banadyne-3 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304585 | Banadyne-3 5 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304585 | Banadyne-3 5 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304585 | Banadyne-3 5 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304852 | brompheniramine maleate 0.133 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1304853 | APAP 33.3 MG/ML / Brompheniramine Maleate 0.133 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304853 | APAP 33.3 MG/ML / Brompheniramine Maleate 0.133 MG/ML / Pseudoephedrine Hydrochloride 2 MG/ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304869 | crude coal tar 0.8 % (coal tar solution 5 % ) Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304869 | crude coal tar 0.8 % (coal tar solution 5 % ) Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304870 | coal tar 8 MG/ML [Tegrin Medicated] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304871 | coal tar 8 MG/ML Topical Cream [Tegrin Medicated] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304871 | coal tar 8 MG/ML Topical Cream [Tegrin Medicated] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304871 | coal tar 8 MG/ML Topical Cream [Tegrin Medicated] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304877 | coal tar 10 MG/ML [Perfect Coat] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304878 | Perfect Coat 5 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304878 | Perfect Coat 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304878 | Perfect Coat 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304878 | Perfect Coat 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304879 | coal tar solution 10 % / salicylic acid 3 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1304879 | coal tar solution 10 % / salicylic acid 3 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1304879 | coal tar solution 10 % / salicylic acid 3 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304882 | coal tar solution 12.5 % / menthol 1.5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304882 | coal tar solution 12.5 % / menthol 1.5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304882 | coal tar solution 12.5 % / menthol 1.5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304883 | coal tar 0.01 MG/MG [Estar] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304884 | coal tar 0.01 MG/MG Topical Gel [Estar] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304884 | coal tar 0.01 MG/MG Topical Gel [Estar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304884 | coal tar 0.01 MG/MG Topical Gel [Estar] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304885 | coal tar 0.0175 MG/MG [Psorigel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1304886 | coal tar 0.0175 MG/MG Topical Gel [Psorigel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1304886 | coal tar 0.0175 MG/MG Topical Gel [Psorigel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304886 | coal tar 0.0175 MG/MG Topical Gel [Psorigel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1304956 | Atopalm First Aid Moisturizing and Pain Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1304958 | bacitracin / neomycin / polymyxin B / pramoxine Topical Ointment [Atopalm First Aid Moisturizing and Pain Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1304959 | Atopalm First Aid Moisturizing and Pain Relief Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1304965 | benzocaine / cetylpyridinium / menthol / zinc chloride Mucous Membrane Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1304966 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.15 % / zinc chloride 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304966 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.15 % / zinc chloride 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304966 | benzocaine 2 % / cetylpyridinium chloride 0.1 % / menthol 0.15 % / zinc chloride 0.1 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304967 | Bucalsep | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304968 | benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 1.5 MG/ML / zinc chloride 1 MG/ML [Bucalsep] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304969 | benzocaine / cetylpyridinium / menthol / zinc chloride Mucous Membrane Topical Solution [Bucalsep] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304970 | Bucalsep Mucosal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304971 | Bucalsep 2 % / 0.1 % / 0.15 % / 0.1 % Mucous Membrane Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304971 | Bucalsep 2 % / 0.1 % / 0.15 % / 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304971 | Bucalsep 2 % / 0.1 % / 0.15 % / 0.1 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304971 | Bucalsep 2 % / 0.1 % / 0.15 % / 0.1 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304974 | icosapent ethyl | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1304975 | icosapent ethyl 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304976 | icosapent ethyl Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1304977 | icosapent ethyl Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1304978 | icosapent ethyl Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1304979 | icosapent ethyl 1 GM Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304979 | icosapent ethyl 1 GM Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304979 | icosapent ethyl 1 GM Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304980 | Vascepa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304981 | icosapent ethyl 1000 MG [Vascepa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304982 | icosapent ethyl Oral Capsule [Vascepa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1304983 | Vascepa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304984 | Vascepa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1304985 | Vascepa 1 GM Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1304985 | Vascepa 1 GM Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304985 | Vascepa 1 GM Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304985 | Vascepa 1 GM Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304988 | FALMINA 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1304988 | FALMINA 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304988 | FALMINA 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304990 | Vincristine sulfate liposome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1304990 | Vincristine sulfate liposome | Designated preferred name (PT) | YES | |
RxCUI: 1304990 | Vincristine sulfate liposome | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304990 | Vincristine sulfate liposome | Full form of descriptor (FN) | YES | |
RxCUI: 1304990 | Vincristine sulfate liposome | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
RxCUI: 1304991 | Vincristine liposome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1304991 | Vincristine liposome | Designated preferred name (PT) | NO | |
RxCUI: 1304991 | Vincristine liposome | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1304991 | Vincristine liposome | Full form of descriptor (FN) | NO | |
RxCUI: 1304992 | vinCRIStine sulfate liposome 0.16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1304992 | vinCRIStine sulfate liposome 0.16 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1304995 | vinCRIStine sulfate liposome 5 MG in 31 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304996 | Marqibo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1304997 | vinCRIStine sulfate liposome 0.16 MG/ML [Marqibo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1304997 | vinCRIStine sulfate liposome 0.16 MG/ML [Marqibo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1304999 | Marqibo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305000 | Marqibo 5 MG in 31 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305000 | Marqibo 5 MG in 31 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305000 | Marqibo 5 MG in 31 ML Injection | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305000 | Marqibo 5 MG in 31 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305000 | Marqibo 5 MG in 31 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305089 | ELINEST 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1305089 | ELINEST 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305089 | ELINEST 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305090 | colloidal oatmeal 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305091 | colloidal oatmeal 2.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305091 | colloidal oatmeal 2.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305091 | colloidal oatmeal 2.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305092 | sodium bicarbonate 0.417 MEQ/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305093 | sodium bicarbonate 525 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305093 | sodium bicarbonate 525 MG per 15 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305093 | sodium bicarbonate 525 MG per 15 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305094 | Desempacho | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305095 | sodium bicarbonate 0.417 MEQ/ML [Desempacho] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305096 | sodium bicarbonate Oral Solution [Desempacho] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305097 | Desempacho Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305098 | Desempacho Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305099 | sodium bicarbonate 0.417 MEQ/ML Oral Solution [Desempacho] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305099 | sodium bicarbonate 0.417 MEQ/ML Oral Solution [Desempacho] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305099 | sodium bicarbonate 0.417 MEQ/ML Oral Solution [Desempacho] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305099 | sodium bicarbonate 0.417 MEQ/ML Oral Solution [Desempacho] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305100 | ethanol 75 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305100 | ethanol 75 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305100 | ethanol 75 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305106 | OC 8 Adult Acne | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1305107 | benzoyl peroxide 0.07 MG/MG [OC 8 Adult Acne] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305108 | benzoyl peroxide Topical Gel [OC 8 Adult Acne] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1305109 | OC 8 Adult Acne Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305110 | OC8 Adult Acne Treatment 7 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305110 | OC8 Adult Acne Treatment 7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305110 | OC8 Adult Acne Treatment 7 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305110 | OC8 Adult Acne Treatment 7 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305119 | eprinomectin 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305120 | eprinomectin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1305121 | eprinomectin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1305122 | eprinomectin 5 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305122 | eprinomectin 5 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305122 | eprinomectin 5 % Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305123 | Longrange | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305124 | eprinomectin 50 MG/ML [Longrange] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305125 | eprinomectin Injectable Solution [Longrange] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305126 | Longrange Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305127 | LongRange 5 % Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305127 | LongRange 5 % Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305127 | LongRange 5 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305127 | LongRange 5 % Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305129 | menthol 2.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305130 | menthol 2.2 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305130 | menthol 2.2 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305135 | alpha-Tocopherol Acetate 30 UNT / vit-C 25 MG / Cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / DOSS Sodium 55 MG / Ferrous fumarate 30 MG / folate 1.24 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305135 | alpha-Tocopherol Acetate 30 UNT / vit-C 25 MG / Cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / DOSS Sodium 55 MG / Ferrous fumarate 30 MG / folate 1.24 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305135 | alpha-Tocopherol Acetate 30 UNT / vit-C 25 MG / Cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / DOSS Sodium 55 MG / Ferrous fumarate 30 MG / folate 1.24 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305135 | alpha-Tocopherol Acetate 30 UNT / vit-C 25 MG / Cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / DOSS Sodium 55 MG / Ferrous fumarate 30 MG / folate 1.24 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305135 | alpha-Tocopherol Acetate 30 UNT / vit-C 25 MG / Cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / DOSS Sodium 55 MG / Ferrous fumarate 30 MG / folate 1.24 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305136 | docosahexaenoic acid 325 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305137 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305137 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305137 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305137 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305137 | alpha Tocopherol 30 UNT / vit-C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / DOSS Sodium 55 MG / Ferrous fumarate 29 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305138 | Nexa Select | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305139 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG [Nexa Select] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305140 | alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoate / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule [Nexa Select] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305141 | Nexa Select Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305142 | Nexa Select Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305143 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305143 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305143 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305143 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305143 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 325 MG / docusate sodium 55 MG / ferrous fumarate 29 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Nexa Select] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305184 | alpha-tocopherol acetate 1.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305185 | ascorbic acid 16 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305186 | biotin 0.004 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305187 | dexpanthenol 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305188 | ergocalciferol 0.002 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305189 | folic acid 0.028 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305190 | niacinamide 3.4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305191 | pyridoxine hydrochloride 0.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305192 | riboflavin 0.28 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305193 | thiamine hydrochloride 0.24 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305194 | vitamin A 0.14 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305195 | vitamin B12 0.0002 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305196 | vitamin K1 0.04 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305197 | alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1305198 | alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1305199 | alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305200 | alpha-tocopherol acetate 1.4 MG/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / vitamin D 0.002 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vit-B1 hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305201 | MVI Pediatric | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1305202 | alpha-tocopherol acetate 1.4 MG/ML / ascorbic acid 16 MG/ML / biotin 0.004 MG/ML / dexpanthenol 1 MG/ML / ergocalciferol 0.002 MG/ML / folic acid 0.028 MG/ML / niacinamide 3.4 MG/ML / pyridoxine hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / thiamine hydrochloride 0.24 MG/ML / vitamin A 0.14 MG/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML [MVI Pediatric] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305203 | alpha tocopherol / ascorbic acid / biotin / dexpanthenol / ergocalciferol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Solution [MVI Pediatric] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1305204 | MVI Pediatric Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305205 | M.V.I. Pediatric (alpha-tocopherol acetate 7 MG / ascorbic acid 80 MG / biotin 20 MCG / ergocalciferol 10 MCG / cyanocobalmin 1 MCG / dexpanthenol 5 MG / folic acid 140 MCG / niacinamide 17 MG / phytonadione 200 MCG / pyridoxine hydrochloride 1 MG / retinol 0.7 MG / riboflavin 1.4 MG / thiamine hydrochloride 1.2 MG) per 5 mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305206 | Atopalm | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305207 | menthol 100 MG/ML [Atopalm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305208 | menthol Topical Cream [Atopalm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305209 | Atopalm Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305210 | ATOPALM Pain Relieving 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305210 | ATOPALM Pain Relieving 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305210 | ATOPALM Pain Relieving 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305210 | ATOPALM Pain Relieving 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305210 | ATOPALM Pain Relieving 10 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305211 | menthol 0.025 MG/MG [Atopalm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305212 | menthol Topical Gel [Atopalm] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305213 | ATOPALM 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305213 | ATOPALM 2.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305213 | ATOPALM 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305213 | ATOPALM 2.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305214 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305214 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305214 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305214 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305215 | alpha-tocopherol acetate 1.4 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305216 | vitamin A palmitate 460 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305217 | alpha-tocopherol acetate 1.4 UNT/ML / vit-C 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folate 0.028 MG/ML / niacinamide 3.4 MG/ML / vitamin B6 hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / vitamin B1 hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305218 | Infuvite Pediatric | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1305219 | alpha-tocopherol acetate 1.4 UNT/ML / ascorbic acid 16 MG/ML / biotin 0.004 MG/ML / cholecalciferol 80 UNT/ML / dexpanthenol 1 MG/ML / folic acid 0.028 MG/ML / niacinamide 3.4 MG/ML / pyridoxine hydrochloride 0.2 MG/ML / riboflavin 0.28 MG/ML / thiamine hydrochloride 0.24 MG/ML / vitamin A palmitate 460 UNT/ML / vitamin B12 0.0002 MG/ML / vitamin K1 0.04 MG/ML [Infuvite Pediatric] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305220 | alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin A / vitamin B12 / vitamin K1 Injectable Solution [Infuvite Pediatric] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1305221 | Infuvite Pediatric Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305222 | Infuvite Pediatric 1.4 UNT/mL / 16 MG/mL / 0.004 MG/mL / 80 UNT/mL / 1 MG/mL / 0.028 MG/mL / 3.4 MG/mL / 0.2 MG/mL / 460 UNT/mL / 0.28 MG/mL / 0.24 MG/mL / 0.0002 MG/mL / 0.04 MG/mL Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305223 | zinc gluconate 110 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305224 | zinc gluconate 110 MG (zinc 15.4 MG) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305224 | zinc gluconate 110 MG (zinc 15.4 MG) Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305263 | mepivacaine HCl 3 % in 1.7 mL Dental Cartridge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305263 | mepivacaine HCl 3 % in 1.7 mL Dental Cartridge | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305263 | mepivacaine HCl 3 % in 1.7 mL Dental Cartridge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305264 | Auvi-Q | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1305265 | EPINEPHrine 1 MG/ML [Auvi-Q] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305265 | EPINEPHrine 1 MG/ML [Auvi-Q] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305267 | Auvi-Q Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305268 | Auvi-Q 0.15 MG in 0.15 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305268 | Auvi-Q 0.15 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305268 | Auvi-Q 0.15 MG in 0.15 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305268 | Auvi-Q 0.15 MG in 0.15 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305268 | Auvi-Q 0.15 MG in 0.15 ML Auto-Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305269 | Auvi-Q 0.3 MG in 0.3 ML Auto-Injector | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305270 | Prenexa Premier | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305272 | alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoate / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule [Prenexa Premier] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305273 | Prenexa Premier Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305274 | Prenexa Premier Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305278 | docosahexaenoic acid 310 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305279 | alpha Tocopherol 30 UNT / vitamin C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / DOSS Sodium 55 MG / Ferrous fumarate 27 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305279 | alpha Tocopherol 30 UNT / vitamin C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / DOSS Sodium 55 MG / Ferrous fumarate 27 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305279 | alpha Tocopherol 30 UNT / vitamin C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / DOSS Sodium 55 MG / Ferrous fumarate 27 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305279 | alpha Tocopherol 30 UNT / vitamin C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / DOSS Sodium 55 MG / Ferrous fumarate 27 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305279 | alpha Tocopherol 30 UNT / vitamin C 28 MG / Cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / DOSS Sodium 55 MG / Ferrous fumarate 27 MG / folate 1.25 MG / vitamin B6 Hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305280 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG [Prenexa Premier] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305281 | alpha tocopherol 30 UNT / ascorbic acid 28 MG / cholecalciferol 800 UNT / docosahexaenoic acid 310 MG / docusate sodium 55 MG / ferrous fumarate 27 MG / folic acid 1.25 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [Prenexa Premier] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305282 | Thionex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305283 | lindane 10 MG/ML [Thionex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305284 | lindane Medicated Shampoo [Thionex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305285 | Thionex Shampoo Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305286 | lindane 10 MG/ML Medicated Shampoo [Thionex] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305286 | lindane 10 MG/ML Medicated Shampoo [Thionex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305286 | lindane 10 MG/ML Medicated Shampoo [Thionex] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305331 | sulfamethazine 5000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305332 | sulfamethazine 5000 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305332 | sulfamethazine 5000 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305333 | sulfamethazine 5000 MG [Sulmet] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305334 | sulfamethazine Oral Tablet [Sulmet] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305335 | Sulmet 5 GM Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305335 | Sulmet 5 GM Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305335 | Sulmet 5 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305335 | Sulmet 5 GM Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305336 | zinc oxide 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305337 | zinc oxide 40 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305337 | zinc oxide 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305337 | zinc oxide 40 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305337 | zinc oxide 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305459 | dextromethorphan HBr 30 MG / guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305459 | dextromethorphan HBr 30 MG / guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305459 | dextromethorphan HBr 30 MG / guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305459 | dextromethorphan HBr 30 MG / guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305515 | 1,1-difluoroethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305516 | 1,3-dichloro-2-propanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305517 | 2-ethylhexanoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305520 | Lactitol monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305520 | Lactitol monohydrate | Designated preferred name (PT) | YES | |
RxCUI: 1305520 | Lactitol monohydrate | Full form of descriptor (FN) | YES | |
RxCUI: 1305527 | lactose monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305530 | barium carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305532 | tangerine peel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305536 | apricot kernal oil PEG-6 esters | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305544 | anhydrous liquid lanolin | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1305545 | Tasmanian bluegum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305545 | Tasmanian bluegum leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305545 | Tasmanian bluegum leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305546 | sucrose syrup | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1305547 | titanium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305548 | hexylene glycol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305549 | Camellia oleifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305550 | marijuana seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305550 | marijuana seed oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305551 | Carya laciniosa pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305552 | methyl pyrrolidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305552 | methyl pyrrolidone | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305553 | Adenophora stricta root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305554 | Alcloxa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305554 | Alcloxa | Designated preferred name (PT) | YES | |
RxCUI: 1305554 | Alcloxa | Full form of descriptor (FN) | YES | |
RxCUI: 1305555 | aluminum dimyristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305556 | aluminum hydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305558 | Ammonia (13-N) | Designated preferred name (PT) | YES | |
RxCUI: 1305558 | Ammonia (13-N) | Full form of descriptor (FN) | YES | |
RxCUI: 1305558 | Ammonia (13-N) | Designated preferred name (PT) | YES | |
RxCUI: 1305558 | Ammonia (13-N) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305558 | Ammonia (13-N) | Full form of descriptor (FN) | YES | |
RxCUI: 1305559 | ammonium acryloyldimethyltaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305560 | FD&C red 40 lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305564 | D&C yellow no. 10 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305564 | D&C yellow no. 10 | Full form of descriptor (FN) | YES | |
RxCUI: 1305564 | D&C yellow no. 10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305564 | D&C yellow no. 10 | Designated preferred name (PT) | YES | |
RxCUI: 1305564 | D&C yellow no. 10 | Full form of descriptor (FN) | YES | |
RxCUI: 1305564 | D&C yellow no. 10 | Designated preferred name (PT) | YES | |
RxCUI: 1305565 | witch hazel Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1305566 | witch hazel 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305566 | witch hazel 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305566 | witch hazel 0.1 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305567 | D&C yellow no. 10, aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305574 | FD&C yellow no. 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305576 | Metanil yellow | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305576 | Metanil yellow | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305576 | Metanil yellow | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305576 | Metanil yellow | Designated preferred name (PT) | NO | |
RxCUI: 1305576 | Metanil yellow | Full form of descriptor (FN) | NO | |
RxCUI: 1305576 | Metanil yellow | Designated preferred name (PT) | NO | |
RxCUI: 1305576 | Metanil yellow | Full form of descriptor (FN) | NO | |
RxCUI: 1305576 | Metanil yellow | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305578 | FD&C yellow no. 5 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305578 | FD&C yellow no. 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305579 | light green SF yellowish | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305581 | D&C yellow no.11 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305582 | ferric oxide yellow | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305585 | synthetic yellow iron oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305587 | dexbrompheniramine maleate 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305588 | pseudoephedrine HCl 120 MG / dexbrompheniramine maleate 6 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305588 | pseudoephedrine HCl 120 MG / dexbrompheniramine maleate 6 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305591 | dexbrompheniramine maleate 6 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305595 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305595 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305600 | Capryloyl glycine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305600 | Capryloyl glycine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305600 | Capryloyl glycine | Designated preferred name (PT) | YES | |
RxCUI: 1305600 | Capryloyl glycine | Full form of descriptor (FN) | YES | |
RxCUI: 1305601 | carbomer interpolymer type A (allyl sucrose crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1305603 | guaiFENesin 600 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1305606 | guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305606 | guaifenesin 600 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305608 | Fennel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305608 | Fennel oil | Designated preferred name (PT) | YES | |
RxCUI: 1305608 | Fennel oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305609 | L-histidine monohydrochloride monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305609 | L-histidine monohydrochloride monohydrate | Designated preferred name (PT) | YES | |
RxCUI: 1305609 | L-histidine monohydrochloride monohydrate | Full form of descriptor (FN) | YES | |
RxCUI: 1305609 | L-histidine monohydrochloride monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305616 | Fe heme polypeptide 12 MG [Proferrin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305617 | Fe heme polypeptide Oral Tablet [Proferrin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1305618 | Proferrin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305619 | Proferrin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1305620 | Proferrin ES 12 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305620 | Proferrin ES 12 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305620 | Proferrin ES 12 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305620 | Proferrin ES 12 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305630 | Zingiber cassumunar root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305631 | Camelina sativa seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305633 | Chamaecyparis obtusa wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305634 | cinnamon oil, bark | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305635 | Echium plantagineum seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305636 | Mentha arvensis flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305638 | Almond oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305638 | Almond oil | Designated preferred name (PT) | YES | |
RxCUI: 1305638 | Almond oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305638 | Almond oil | Designated preferred name (PT) | YES | |
RxCUI: 1305638 | Almond oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305639 | Amyris balsamifera oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305640 | Angelica root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305641 | Angelica seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305642 | argan oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305643 | Atractylodes lancea root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305643 | Atractylodes lancea root oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305644 | benzocaine 200 MG/ML [BOIL-EASE] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305645 | benzocaine Medicated Pad [BOIL-EASE] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305646 | BOIL-EASE Medicated Pad or Tape | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305647 | benzocaine 200 MG/ML Medicated Pad [BOIL-EASE] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305647 | benzocaine 200 MG/ML Medicated Pad [BOIL-EASE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305647 | benzocaine 200 MG/ML Medicated Pad [BOIL-EASE] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305648 | Azadirachta indica seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305649 | babassu oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305650 | bay leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305651 | Bergamot oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305651 | Bergamot oil | Designated preferred name (PT) | YES | |
RxCUI: 1305651 | Bergamot oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305652 | Indian frankincense resin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305652 | Indian frankincense resin oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305653 | wormwood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305654 | West Indian lemongrass oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305655 | sweet marjoram oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305656 | star anise oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305657 | Mentha spicata oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305657 | Mentha spicata oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305657 | Mentha spicata oil | Designated preferred name (PT) | YES | |
RxCUI: 1305657 | Mentha spicata oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305658 | sheanut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305659 | Salix alba bark volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305660 | Santalum spicatum oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305661 | sage oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305662 | Rosa moschata oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305663 | Rosa damascena flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305664 | Rosa centifolia flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305665 | Ribes nigrum seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305669 | polyoxyl 40 hydrogenated castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305670 | Pine needle oil | Designated preferred name (PT) | YES | |
RxCUI: 1305670 | Pine needle oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305670 | Pine needle oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305670 | Pine needle oil | Designated preferred name (PT) | YES | |
RxCUI: 1305670 | Pine needle oil | Full form of descriptor (FN) | YES | |
RxCUI: 1305674 | carbetapentane tannate 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305675 | pseudoephedrine tannate 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305676 | carbetapentane tannate 25 MG / pseudoephedrine tannate 75 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305676 | carbetapentane tannate 25 MG / pseudoephedrine tannate 75 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305715 | rosa canina fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305716 | mandarin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305719 | cucumber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305720 | Chinese cinnamon extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305723 | saccharin sodium dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305724 | Coconut diethanolamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305724 | Coconut diethanolamide | Designated preferred name (PT) | YES | |
RxCUI: 1305724 | Coconut diethanolamide | Full form of descriptor (FN) | YES | |
RxCUI: 1305724 | Coconut diethanolamide | Designated preferred name (PT) | YES | |
RxCUI: 1305724 | Coconut diethanolamide | Full form of descriptor (FN) | YES | |
RxCUI: 1305725 | lime (citrus) extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305727 | hydroxyethyl cellulose (140 MPA.S at 5 % ) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305727 | hydroxyethyl cellulose (140 MPA.S at 5 % ) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305728 | peg-150 disetearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305729 | Dermaseptin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305732 | Dermaseptin Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305734 | zinc oxide 0.207 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305735 | menthol 0.5 % / zinc oxide 20.7 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305735 | menthol 0.5 % / zinc oxide 20.7 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305735 | menthol 0.5 % / zinc oxide 20.7 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305738 | carbomer 940 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305738 | carbomer 940 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305738 | carbomer 940 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305738 | carbomer 940 | Designated preferred name (PT) | YES | |
RxCUI: 1305738 | carbomer 940 | Full form of descriptor (FN) | YES | |
RxCUI: 1305738 | carbomer 940 | Designated preferred name (PT) | YES | |
RxCUI: 1305738 | carbomer 940 | Full form of descriptor (FN) | YES | |
RxCUI: 1305739 | ethylcellulose (100 MPA S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305743 | Ilex paraguariensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305744 | cyclomethicone 5 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305745 | Chamaecyparis obtusa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305748 | glycereth-2 cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305749 | glyceryl dibehenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305749 | glyceryl dibehenate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305751 | methyl chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305755 | zinc lactate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305757 | Tri-Lo-Marzia 28 Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
RxCUI: 1305757 | Tri-Lo-Marzia 28 Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305757 | Tri-Lo-Marzia 28 Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305758 | povidone K29-32 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1305759 | povidone K12 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1305760 | povidone (K-30) simethicone emulsion | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1305761 | Saposhnikovia divaricata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305762 | Colocasia esculenta root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305763 | milk fat, cow | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305764 | SD alcohol 40 (20% w/w) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1305765 | dextromethorphan tannate 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305766 | brompheniramine tannate 8 MG / dextromethorphan tannate 20 MG / phenylephrine tannate 20 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305766 | brompheniramine tannate 8 MG / dextromethorphan tannate 20 MG / phenylephrine tannate 20 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305769 | phenylephrine tannate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305770 | chlorpheniramine tannate 2 MG / methscopolamine nitrate 1.5 MG / phenylephrine tannate 10 MG per 5 ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305770 | chlorpheniramine tannate 2 MG / methscopolamine nitrate 1.5 MG / phenylephrine tannate 10 MG per 5 ML Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305773 | dexchlorpheniramine tannate 0.7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305774 | dextromethorphan tannate 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305775 | dexchlorpheniramine tannate 3.5 MG / dextromethorphan tannate 30 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305775 | dexchlorpheniramine tannate 3.5 MG / dextromethorphan tannate 30 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305778 | dextromethorphan tannate 6 MG/ML / pseudoephedrine tannate 9 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305781 | brompheniramine tannate 6 MG / hydrocodone bitartrate 6 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305781 | brompheniramine tannate 6 MG / hydrocodone bitartrate 6 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305781 | brompheniramine tannate 6 MG / hydrocodone bitartrate 6 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305781 | brompheniramine tannate 6 MG / hydrocodone bitartrate 6 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305782 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML [SymTan A] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305782 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML [SymTan A] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305783 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan A] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305783 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan A] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305783 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan A] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305783 | brompheniramine tannate 1.2 MG/ML / hydrocodone bitartrate 1.2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan A] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305784 | hydrocodone bitartrate 10 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305784 | hydrocodone bitartrate 10 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305784 | hydrocodone bitartrate 10 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305784 | hydrocodone bitartrate 10 MG / pseudoephedrine tannate 45 MG per 5 ML Extended Release Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305785 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML [SymTan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305785 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML [SymTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305786 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305786 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305786 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305786 | hydrocodone bitartrate 2 MG/ML / pseudoephedrine tannate 9 MG/ML Extended Release Suspension [SymTan] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1305787 | carbetapentane tannate 5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305788 | pseudoephedrine tannate 15 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1305789 | carbetapentane tannate 5 MG/ML / pseudoephedrine tannate 15 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305808 | sodium picosulfate 10 MG / magnesium oxide 3.5 GM / citric acid 12 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305808 | sodium picosulfate 10 MG / magnesium oxide 3.5 GM / citric acid 12 GM Powder for Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305808 | sodium picosulfate 10 MG / magnesium oxide 3.5 GM / citric acid 12 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305810 | Prepopik 10 MG / 3.5 GM / 12 GM Powder for Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305810 | Prepopik 10 MG / 3.5 GM / 12 GM Powder for Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305810 | Prepopik 10 MG / 3.5 GM / 12 GM Powder for Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305866 | Band-Aid Anti-Itch | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305867 | camphor 0.0045 MG/MG [Band-Aid Anti-Itch] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305868 | camphor Topical Gel [Band-Aid Anti-Itch] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305869 | Band-Aid Anti-Itch Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305870 | BAND-AID Anti-Itch 0.45 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305870 | BAND-AID Anti-Itch 0.45 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305870 | BAND-AID Anti-Itch 0.45 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305870 | BAND-AID Anti-Itch 0.45 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305871 | Arthur Itis | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305872 | capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML [Arthur Itis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305873 | capsaicin / trolamine salicylate Topical Cream [Arthur Itis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305874 | Arthur Itis Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305875 | capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML Topical Cream [Arthur Itis] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305875 | capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML Topical Cream [Arthur Itis] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305875 | capsaicin 0.25 MG/ML / trolamine salicylate 100 MG/ML Topical Cream [Arthur Itis] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305877 | Nullo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1305878 | chlorophyllin copper complex 33.3 MG [Nullo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305879 | chlorophyllin copper complex Oral Tablet [Nullo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1305880 | Nullo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305881 | Nullo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1305882 | nullo 33.3 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305882 | nullo 33.3 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305882 | nullo 33.3 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305883 | coal tar 250 MG/ML [Oxipor VHC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305884 | Oxipor VHC 25 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305884 | Oxipor VHC 25 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305884 | Oxipor VHC 25 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305885 | coal tar 70 MG/ML [Tegrin Medicated] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1305886 | Tegrin 7 % Medicated Shampoo | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305886 | Tegrin 7 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305886 | Tegrin 7 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305888 | fibrin sealant (thrombin 6.5 UNT/ML, human) Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305888 | fibrin sealant (thrombin 6.5 UNT/ML, human) Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305888 | fibrin sealant (thrombin 6.5 UNT/ML, human) Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305890 | ARTISS, Fibrin Sealant (Human) Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1305890 | ARTISS, Fibrin Sealant (Human) Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305890 | ARTISS, Fibrin Sealant (Human) Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305891 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 2 mL Prefilled Syringe, frozen | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305891 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 2 mL Prefilled Syringe, frozen | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305891 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 2 mL Prefilled Syringe, frozen | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305892 | ARTISS (Frozen) fibrin sealant (human) topical solution 2 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305892 | ARTISS (Frozen) fibrin sealant (human) topical solution 2 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305892 | ARTISS (Frozen) fibrin sealant (human) topical solution 2 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305896 | aluminum zirconium tetrachlorohydrex gly | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305899 | aluminum zirconium pentachlorohydrex gly | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1305900 | fibrin sealant (thrombin 600 UNT/ML, human) Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305900 | fibrin sealant (thrombin 600 UNT/ML, human) Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1305902 | fibrinogen, human 115 MG/ML / thrombin, human 600 UNT/ML Topical Solution [Tisseel] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1305902 | fibrinogen, human 115 MG/ML / thrombin, human 600 UNT/ML Topical Solution [Tisseel] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1305907 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 4 mL Prefilled Syringe, frozen | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305907 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 4 mL Prefilled Syringe, frozen | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305907 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 4 mL Prefilled Syringe, frozen | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305908 | ARTISS (Frozen) fibrin sealant (human) topical solution 4 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305908 | ARTISS (Frozen) fibrin sealant (human) topical solution 4 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305908 | ARTISS (Frozen) fibrin sealant (human) topical solution 4 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305909 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 10 mL Prefilled Syringe, frozen | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305909 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 10 mL Prefilled Syringe, frozen | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305909 | fibrin sealant (thrombin 6.5 UNT/mL, human) topical solution 10 mL Prefilled Syringe, frozen | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305910 | ARTISS (Frozen) fibrin sealant (human) topical solution 10 mL Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305910 | ARTISS (Frozen) fibrin sealant (human) topical solution 10 mL Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305910 | ARTISS (Frozen) fibrin sealant (human) topical solution 10 mL Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305911 | camphor 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1305912 | benzyl alcohol / camphor / menthol Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1305913 | benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1305913 | benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305913 | benzyl alcohol 10 % / camphor 0.6 % / menthol 0.4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1305914 | benzyl alcohol 100 MG/ML / camphor 6 MG/ML / menthol 4 MG/ML [Ivy-Dry Cream] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1305915 | benzyl alcohol / camphor / menthol Topical Cream [Ivy-Dry Cream] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1305916 | Ivy-Dry Cream 10 % / 0.6 % / 0.4 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1305916 | Ivy-Dry Cream 10 % / 0.6 % / 0.4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1305916 | Ivy-Dry Cream 10 % / 0.6 % / 0.4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306057 | white pine oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306058 | Tribulus terrestris root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306059 | tildipirosin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306060 | Thermus thermophilus lysate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306061 | tetrakis(1-isocyano-2-methoxy-2-methyl-propane)-copper(i) tetrafluoroborate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306062 | zinc glycinate citrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306063 | Zinc glycinate | Full form of descriptor (FN) | YES | |
RxCUI: 1306063 | Zinc glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306063 | Zinc glycinate | Designated preferred name (PT) | YES | |
RxCUI: 1306063 | Zinc glycinate | Full form of descriptor (FN) | YES | |
RxCUI: 1306063 | Zinc glycinate | Designated preferred name (PT) | YES | |
RxCUI: 1306064 | cefdinir monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306065 | 51-Cr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306065 | 51-Cr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306065 | 51-Cr | Designated preferred name (PT) | NO | |
RxCUI: 1306065 | 51-Cr | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306065 | 51-Cr | Full form of descriptor (FN) | NO | |
RxCUI: 1306065 | 51-Cr | Designated preferred name (PT) | NO | |
RxCUI: 1306065 | 51-Cr | Full form of descriptor (FN) | NO | |
RxCUI: 1306066 | silver citrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306067 | oxidronate disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306068 | oxidronate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306069 | spectinomycin sulfate tetrahydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306073 | ranibizumab 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1306074 | ranibizumab 0.3 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1306074 | ranibizumab 0.3 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306074 | ranibizumab 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306075 | ranibizumab 6 MG/ML [Lucentis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1306076 | LUCENTIS 0.3 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1306076 | LUCENTIS 0.3 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306076 | LUCENTIS 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306077 | urea 180 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1306078 | urea 18 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306078 | urea 18 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306078 | urea 18 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306079 | Rephresh Pro-B | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306082 | Rephresh Pro-B Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306083 | Rephresh Pro-B Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306084 | RepHresh Pro-B 2.5 Billion UNT / 2.5 Billion UNT Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306084 | RepHresh Pro-B 2.5 Billion UNT / 2.5 Billion UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306084 | RepHresh Pro-B 2.5 Billion UNT / 2.5 Billion UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306085 | Alternaria alternata allergenic extract 0.8 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1306086 | Alternaria alternata allergenic extract 0.8 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306086 | Alternaria alternata allergenic extract 0.8 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306086 | Alternaria alternata allergenic extract 0.8 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306086 | Alternaria alternata allergenic extract 0.8 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306087 | UTI Relief | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306088 | phenazopyridine hydrochloride 97.2 MG [UTI Relief] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306089 | phenazopyridine Oral Tablet [UTI Relief] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306090 | UTI Relief Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306091 | UTI Relief Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306092 | UTI Relief 97.2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306092 | UTI Relief 97.2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306092 | UTI Relief 97.2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306093 | chlortetracycline calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306094 | Curcuma zanthorrhiza oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306094 | Curcuma zanthorrhiza oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306095 | pomegranate seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306096 | aluminum zirconium octachlorohydrex gly | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306097 | aluminum zirconium pentachlorohydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306098 | aluminum sulfate tetradecahydrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306099 | bicisate dihydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306100 | bicisate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306103 | laidlomycin propionate potassium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306106 | nicotine bitartrate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306107 | nicotine bitartrate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306107 | nicotine bitartrate | Designated preferred name (PT) | NO | |
RxCUI: 1306107 | nicotine bitartrate | Full form of descriptor (FN) | NO | |
RxCUI: 1306108 | European white birch pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306108 | European white birch pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306108 | European white birch pollen extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306109 | sulfamerazine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306110 | sulfaquinoxaline sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306111 | Sulfaquinoxaline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306111 | Sulfaquinoxaline | Designated preferred name (PT) | NO | |
RxCUI: 1306111 | Sulfaquinoxaline | Full form of descriptor (FN) | NO | |
RxCUI: 1306111 | Sulfaquinoxaline | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
RxCUI: 1306112 | Dibenzothiazyl disulfide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306112 | Dibenzothiazyl disulfide | Designated preferred name (PT) | NO | |
RxCUI: 1306112 | Dibenzothiazyl disulfide | Full form of descriptor (FN) | NO | |
RxCUI: 1306112 | Dibenzothiazyl disulfide | Designated preferred name (PT) | NO | |
RxCUI: 1306112 | Dibenzothiazyl disulfide | Full form of descriptor (FN) | NO | |
RxCUI: 1306114 | ferrous bisglycinate hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306115 | bemotrizinol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306117 | gonadotropin releasing hormone, D-Arg(6) ethyl amide acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306118 | New Zealand green mussel extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306119 | blackfoot abalone extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306120 | Platycladus orientalis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306121 | sulfadimethoxine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306122 | Mycogone nigra allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306123 | adenosine phosphate disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306124 | alpha, alpha-dimethylbenzyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306125 | alpha-amylase A type 1-2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306126 | alpha-bisabolol, (+-)- | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306127 | adenosine triphosphate disodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306128 | Aloe barbadensis leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306128 | Aloe barbadensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306129 | chondroitin sulfate, bovine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306130 | grapefruit seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306131 | Citrus reticulata fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306132 | Citrus reticulata leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306133 | Citrus sinensis flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306134 | Cladanthus mixtus flower volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306135 | Plectranthus barbatus root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306135 | Plectranthus barbatus root oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306136 | copaiba oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306136 | copaiba oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306136 | copaiba oil | Designated preferred name (PT) | YES | |
RxCUI: 1306136 | copaiba oil | Full form of descriptor (FN) | YES | |
RxCUI: 1306137 | Corymbia citriodora leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306138 | Crambe hispanica subsp. abyssinica seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306139 | Vagi-Gard Douche | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306140 | povidone-iodine 100 MG/ML [Vagi-Gard Douche] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306141 | povidone-iodine Douche [Vagi-Gard Douche] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306142 | Vagi-Gard Douche Vaginal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306143 | Vagi-Gard 10 % Douche | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306143 | Vagi-Gard 10 % Douche | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306143 | Vagi-Gard 10 % Douche | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306144 | cranberry seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306145 | cucumber fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306146 | Cymbopogon schoenanthus oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306148 | Chinese cinnamon leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306149 | Citrus aurantiifolia seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306150 | Citrus aurantium flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306151 | Citrus aurantium fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306152 | Citrus limon fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306153 | Citrus aurantium leafy twig oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306154 | Citrus maxima fruit rind oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306155 | Brassica rapa var. rapa oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306156 | Brazil nut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306157 | Cedrus atlantica bark oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306158 | Abies sibirica leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306159 | rapeseed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306159 | rapeseed oil | Designated preferred name (PT) | YES | |
RxCUI: 1306159 | rapeseed oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306159 | rapeseed oil | Full form of descriptor (FN) | YES | |
RxCUI: 1306160 | Calophyllum tacamahaca seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306161 | Camellia japonica seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306162 | Camellia oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306163 | camphor leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306164 | Carapa guianensis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306165 | Althaea officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306166 | mountain arnica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306166 | mountain arnica flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306167 | Angelica dahurica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306168 | balsam fir leefy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306169 | Bambusa bambos stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306169 | Bambusa bambos stem extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306170 | Bambusa vulgaris sap extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306171 | Bambusa vulgaris stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306172 | ceteth-16 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306173 | ceteth-24 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306174 | ceteth-25 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306175 | cetyl betaine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306176 | zinc pyrithione Topical Cream [Dermazinc] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1306177 | DermaZinc 0.25 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306177 | DermaZinc 0.25 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306177 | DermaZinc 0.25 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1306178 | cetyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306179 | cetyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306180 | cetyl myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306181 | cetyl caprylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306181 | cetyl caprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306182 | cetyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306183 | cetyl palmitoleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306184 | cetyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306185 | cetylhydroxyproline palmitamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306187 | Equus caballus collagen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306188 | neopentyl glycol diheptanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306189 | hordeum vulgare root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306190 | batilol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306191 | beach strawberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306192 | behenyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306193 | Bellis perennis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306194 | Chamaemelum nobile flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306195 | Chenopodium quinoa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306196 | chitosan low molecular weight (20-200 MPA.S) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306197 | Acorus gramineus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306198 | ammonio methacrylate copolymer type B | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306199 | alfalfa seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306200 | cholesteryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306201 | choleth-20 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306202 | chondroitin sulfate, porcine | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306203 | Chysanthellum indicum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306204 | Chrysanthemum x morifolium flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306205 | Citrus aurantium flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306206 | Citrus aurantium fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306207 | Citrus maxima fruit rind extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306208 | Citrus maxima leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306209 | Citrus maxima seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306210 | hydrogenated polybutene (370 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306211 | arachidyl propionate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306212 | Arctostaphylos uva-ursi leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306213 | salicylic acid Topical Solution [Propa P.H.] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306214 | Propa P.H. 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306214 | Propa P.H. 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306214 | Propa P.H. 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306215 | Sanafitil | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306216 | salicylic acid 0.02 MG/MG / undecylenic acid 0.1 MG/MG [Sanafitil] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306217 | salicylic acid / undecylenate Topical Ointment [Sanafitil] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306218 | Sanafitil Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306219 | SANAFITIL 2 % / 10 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306219 | SANAFITIL 2 % / 10 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306219 | SANAFITIL 2 % / 10 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306235 | field horsetail top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306235 | field horsetail top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306284 | cobicistat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306284 | cobicistat | Designated preferred name (PT) | YES | |
RxCUI: 1306284 | cobicistat | Full form of descriptor (FN) | YES | |
RxCUI: 1306284 | cobicistat | Designated preferred name (PT) | YES | |
RxCUI: 1306284 | cobicistat | Full form of descriptor (FN) | YES | |
RxCUI: 1306285 | cobicistat 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1306286 | elvitegravir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306286 | elvitegravir | Designated preferred name (PT) | YES | |
RxCUI: 1306286 | elvitegravir | Full form of descriptor (FN) | YES | |
RxCUI: 1306286 | elvitegravir | Designated preferred name (PT) | YES | |
RxCUI: 1306286 | elvitegravir | Full form of descriptor (FN) | YES | |
RxCUI: 1306287 | elvitegravir 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1306288 | cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1306289 | cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1306290 | cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1306291 | cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
RxCUI: 1306292 | elvitegravir 150 MG / cobicistat 150 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1306292 | elvitegravir 150 MG / cobicistat 150 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306293 | Stribild | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1306294 | cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir disoproxil fumarate 300 MG [Stribild] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1306295 | cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil Oral Tablet [Stribild] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1306296 | Stribild Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1306297 | Stribild Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1306298 | Stribild 150 MG / 150 MG / 200 MG / 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1306298 | Stribild 150 MG / 150 MG / 200 MG / 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306298 | Stribild 150 MG / 150 MG / 200 MG / 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306351 | Cetraria islandica whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306351 | Cetraria islandica whole extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306881 | Absidia capillata allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306882 | Amaranthus retroflexus whole allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306882 | Amaranthus retroflexus whole allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306883 | barley malt syrup | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306884 | calcium acetate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306885 | Momordica charantia fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306886 | N-cyclohexyl-2-benzothiazosulfenamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306898 | HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1306898 | HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1306898 | HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1306898 | HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306898 | HYDROmorphone HCl 32 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1306899 | hydromorphone hydrochloride 32 MG [Exalgo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306899 | hydromorphone hydrochloride 32 MG [Exalgo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1306900 | Exalgo 32 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306900 | Exalgo 32 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306900 | Exalgo 32 MG 24HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1306900 | Exalgo 32 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306900 | Exalgo 32 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306901 | hydromorphone hydrochloride 32 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306901 | hydromorphone hydrochloride 32 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1306902 | hydromorphone hydrochloride 32 MG Extended Release Oral Tablet [Exalgo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306902 | hydromorphone hydrochloride 32 MG Extended Release Oral Tablet [Exalgo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306902 | hydromorphone hydrochloride 32 MG Extended Release Oral Tablet [Exalgo] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1306904 | methyl salicylate 0.16 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1306905 | menthol 8 % / methyl salicylate 16 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306905 | menthol 8 % / methyl salicylate 16 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306905 | menthol 8 % / methyl salicylate 16 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306906 | Rocainol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306907 | menthol 0.08 MG/MG / methyl salicylate 0.16 MG/MG [Rocainol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306908 | menthol / methyl salicylate Topical Ointment [Rocainol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306909 | Rocainol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306910 | Rocainol 8 % / 16 % Topical Ointment | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306910 | Rocainol 8 % / 16 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306910 | Rocainol 8 % / 16 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306911 | menthol 0.1 % / zinc oxide 1 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306911 | menthol 0.1 % / zinc oxide 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306911 | menthol 0.1 % / zinc oxide 1 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306911 | menthol 0.1 % / zinc oxide 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306912 | Percara Original | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1306913 | menthol 0.001 MG/MG / zinc oxide 0.01 MG/MG [Percara Original] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1306914 | menthol / zinc oxide Topical Powder [Percara Original] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1306915 | Percara Original Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1306916 | PerCara Original 0.1 % / 1 % Topical Powder | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1306916 | PerCara Original 0.1 % / 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306916 | PerCara Original 0.1 % / 1 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306916 | PerCara Original 0.1 % / 1 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1306923 | petrolatum 0.346 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1306924 | allantoin / petrolatum / zinc oxide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1306925 | allantoin / petrolatum / zinc oxide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1306926 | allantoin / petrolatum / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1306927 | Allantoin 0.01 MG/MG / Petrolatum 0.346 MG/MG / ZNO 0.3 MG/MG Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1306927 | Allantoin 0.01 MG/MG / Petrolatum 0.346 MG/MG / ZNO 0.3 MG/MG Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1306933 | ascorbyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306935 | Brazillian pepper extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306936 | butylparaben sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1306937 | Butylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306937 | Butylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306937 | Butylparaben | Designated preferred name (PT) | YES | |
RxCUI: 1306937 | Butylparaben | Full form of descriptor (FN) | YES | |
RxCUI: 1306937 | Butylparaben | Designated preferred name (PT) | YES | |
RxCUI: 1306937 | Butylparaben | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306937 | Butylparaben | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306937 | Butylparaben | Full form of descriptor (FN) | YES | |
RxCUI: 1306938 | ethyl palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306939 | copper pidolate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1306940 | cetyl PEG-PPG-10-1 dimethicone (HLB 2) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306940 | cetyl PEG-PPG-10-1 dimethicone (HLB 2) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1306941 | cetyl PEG-PPG-10-1 dimethicone (HLB 5) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306942 | barley bran | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306943 | chitosan oligosaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1306944 | ammonium laureth-5 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306945 | diethylhexyl adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306946 | brown iron oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306947 | cocamine oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1306948 | butyloctyl salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307035 | Lens culinaris fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307036 | hydroxyethyl cellulose (4000 CPS at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307037 | hexanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307038 | decyl oleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307039 | methylbenzyl methylbenzimidazole piperidinylmethanone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307040 | brinolase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307040 | brinolase | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307041 | PEG-6 cocamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307042 | polyhydroxystearic acid (2300 MW) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307043 | apricot juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Designated preferred name (PT) | NO | |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Full form of descriptor (FN) | NO | |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Designated preferred name (PT) | NO | |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307044 | 2-bromo-2-(bromomethyl)pentanedinitrile | Full form of descriptor (FN) | NO | |
RxCUI: 1307045 | D&C orange no. 10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307046 | polyoxyl 20 cetostearyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307048 | diethylhexyl carbonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307049 | Litchi fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307050 | methyl dihydrojasmonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307051 | ethanol 75 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307051 | ethanol 75 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307051 | ethanol 75 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307054 | buprenorphine 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307055 | naloxone 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307056 | buprenorphine HCl 4 MG / naloxone HCl 1 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307056 | buprenorphine HCl 4 MG / naloxone HCl 1 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307056 | buprenorphine HCl 4 MG / naloxone HCl 1 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307056 | buprenorphine HCl 4 MG / naloxone HCl 1 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307057 | buprenorphine 4 MG / naloxone 1 MG [Suboxone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307058 | Suboxone 4 MG / 1 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307058 | Suboxone 4 MG / 1 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307058 | Suboxone 4 MG / 1 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307058 | Suboxone 4 MG / 1 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307059 | buprenorphine 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307060 | naloxone 3 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307061 | buprenorphine HCl 12 MG / naloxone HCl 3 MG Sublingual Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307061 | buprenorphine HCl 12 MG / naloxone HCl 3 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307061 | buprenorphine HCl 12 MG / naloxone HCl 3 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307062 | buprenorphine 12 MG / naloxone 3 MG [Suboxone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307063 | Suboxone 12 MG / 3 MG Sublingual Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307063 | Suboxone 12 MG / 3 MG Sublingual Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307063 | Suboxone 12 MG / 3 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307063 | Suboxone 12 MG / 3 MG Sublingual Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307073 | chlorpheniramine maleate 8 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307079 | methyl benzoin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307080 | cyclomethicone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307081 | cyclomethicone 6 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307083 | stearyl ethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307084 | hydroxyethyl cellulose (5000 CPS at 1%) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307085 | 2-(4-(diethylamino)-2-hydroxybenzoyl)benzoic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307086 | PEG-9 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307087 | Caesalpinia spinosa resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307088 | isotridecyl isononanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307090 | pentaerythrityl tetrastearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307091 | heptyl undecylenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307092 | isodecyl neopentanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307093 | stearamidopropyl propylene glycol-dimonium chloride phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307093 | stearamidopropyl propylene glycol-dimonium chloride phosphate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307094 | amnonium acryloyldimethyltaurate - vp copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307096 | PEG-12 glyceryl dimyristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307097 | triethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307098 | PEG-7 glyceryl cocoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307099 | acetyl tetrapeptide-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307100 | neopentyl glycol dicaprylate-dicaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307101 | neopentyl gly dcapryl-dcaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307102 | allyl sucrose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307103 | chlorpheniramine maleate 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307104 | chlorpheniramine maleate 3 MG / hydrocodone bitartrate 5 MG / phenylephrine hydrochloride 7.5 MG per 5 ML Syrup | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307104 | chlorpheniramine maleate 3 MG / hydrocodone bitartrate 5 MG / phenylephrine hydrochloride 7.5 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307104 | chlorpheniramine maleate 3 MG / hydrocodone bitartrate 5 MG / phenylephrine hydrochloride 7.5 MG per 5 ML Syrup | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307104 | chlorpheniramine maleate 3 MG / hydrocodone bitartrate 5 MG / phenylephrine hydrochloride 7.5 MG per 5 ML Syrup | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307106 | succinate dianion | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307106 | succinate dianion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307106 | succinate dianion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307107 | sodium succinate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307108 | chlorpheniramine maleate 0.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307109 | dextromethorphan hydrobromide 2.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307110 | phenylephrine hydrochloride 1.75 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307111 | chlorpheniramine maleate 0.75 MG/ML / dextromethorphan hydrobromide 2.75 MG/ML / phenylephrine hydrochloride 1.75 MG/ML Oral Drops | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307111 | chlorpheniramine maleate 0.75 MG/ML / dextromethorphan hydrobromide 2.75 MG/ML / phenylephrine hydrochloride 1.75 MG/ML Oral Drops | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307141 | dibenzylidene sorbitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307142 | ricinoleamidopropyl ethyldimonium ethosulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307143 | silk amino acids | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307144 | Elaeis guineensis fruit butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307145 | caprylhydroxamic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307146 | brompheniramine tannate 2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307147 | brompheniramine tannate 10 MG / dextromethorphan tannate 30 MG / phenylephrine tannate 25 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307147 | brompheniramine tannate 10 MG / dextromethorphan tannate 30 MG / phenylephrine tannate 25 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307148 | neopentyl glycol diethylhexanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307149 | tomato juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307150 | oolong tea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307151 | Nelumbo nucifera flower wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307152 | glyceryl monocaprylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307152 | glyceryl monocaprylate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307153 | glucosyl steviol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307154 | C20-40 pareth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307155 | glycol palmitate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307156 | butylphenyl methylpropional | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307157 | di-PPG-3 myristyl ether adipate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307158 | sodium phosphate, tribasic anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307160 | Respivent | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1307161 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG [Respivent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1307162 | methscopolamine / pseudoephedrine Extended Release Oral Tablet [Respivent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1307163 | Respivent Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1307164 | Respivent Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1307165 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Respivent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1307165 | 12 HR methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Respivent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307166 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Respivent] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1307166 | methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet [Respivent] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307167 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307167 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307167 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307167 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG 12 HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307168 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307168 | guaifenesin 125 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307225 | chlorpheniramine tannate 4 MG / phenylephrine tannate 20 MG per 5 ML Extended Release Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307225 | chlorpheniramine tannate 4 MG / phenylephrine tannate 20 MG per 5 ML Extended Release Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307226 | 12 HR guaifenesin 500 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307226 | 12 HR guaifenesin 500 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307233 | guaifenesin 500 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307233 | guaifenesin 500 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307235 | guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307235 | guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307235 | guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307242 | guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307242 | guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307244 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307244 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307244 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307244 | acetaminophen 325 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307247 | guaiFENesin 300 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307248 | guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307248 | guaifenesin 300 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307253 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307253 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307253 | dextromethorphan HBr 20 MG / guaiFENesin 400 MG / pseudoephedrine HCl 60 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1307260 | sodium lauroamphoacetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307262 | glyceryl linolenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307263 | distearyl ether | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307267 | guaifenesin 600 MG / phenylpropanolamine hydrochloride 75 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307267 | guaifenesin 600 MG / phenylpropanolamine hydrochloride 75 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307268 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307269 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307270 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML [Je-Vax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1307271 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension [Je-Vax] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1307271 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension [Je-Vax] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307271 | Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.0000000385 MG/ML Injectable Suspension [Je-Vax] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307298 | enzalutamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307298 | enzalutamide | Designated preferred name (PT) | YES | |
RxCUI: 1307298 | enzalutamide | Full form of descriptor (FN) | YES | |
RxCUI: 1307298 | enzalutamide | Designated preferred name (PT) | YES | |
RxCUI: 1307298 | enzalutamide | Full form of descriptor (FN) | YES | |
RxCUI: 1307299 | enzalutamide 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307300 | enzalutamide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307300 | enzalutamide Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1307300 | enzalutamide Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1307301 | enzalutamide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307302 | enzalutamide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1307303 | enzalutamide 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307303 | enzalutamide 40 MG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1307303 | enzalutamide 40 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307303 | enzalutamide 40 MG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1307304 | Xtandi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1307305 | enzalutamide 40 MG [Xtandi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307306 | enzalutamide Oral Capsule [Xtandi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1307307 | Xtandi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307308 | Xtandi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307309 | Xtandi 40 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307309 | Xtandi 40 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307309 | Xtandi 40 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307310 | glyceryl caprylocaprate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307310 | glyceryl caprylocaprate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307312 | polyethylene glycol 8000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307313 | polyethylene glycol 800 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307314 | robusta coffee bean extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307404 | linaclotide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307404 | linaclotide | Designated preferred name (PT) | YES | |
RxCUI: 1307404 | linaclotide | Full form of descriptor (FN) | YES | |
RxCUI: 1307404 | linaclotide | Designated preferred name (PT) | YES | |
RxCUI: 1307404 | linaclotide | Full form of descriptor (FN) | YES | |
RxCUI: 1307405 | linaclotide 0.145 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307406 | linaclotide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307406 | linaclotide Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1307406 | linaclotide Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1307407 | linaclotide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307408 | linaclotide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1307409 | linaclotide 145 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307409 | linaclotide 145 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307409 | linaclotide 145 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307409 | linaclotide 145 MCG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1307409 | linaclotide 145 MCG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1307410 | Linzess | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1307411 | linaclotide 0.145 MG [Linzess] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307412 | linaclotide Oral Capsule [Linzess] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1307413 | Linzess Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307414 | Linzess Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307415 | Linzess 145 MCG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307415 | Linzess 145 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307415 | Linzess 145 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307415 | Linzess 145 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307418 | linaclotide 0.29 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307419 | linaclotide 290 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307419 | linaclotide 290 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307419 | linaclotide 290 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307419 | linaclotide 290 MCG Oral Capsule | Designated preferred name (PT) | YES | |
RxCUI: 1307419 | linaclotide 290 MCG Oral Capsule | Full form of descriptor (FN) | YES | |
RxCUI: 1307420 | linaclotide 0.29 MG [Linzess] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307421 | Linzess 290 MCG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307421 | Linzess 290 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307421 | Linzess 290 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307421 | Linzess 290 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307424 | sildenafil 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307425 | sildenafil Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307426 | sildenafil Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Designated preferred name (PT) | YES | |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307427 | sildenafil 10 MG in 1 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307428 | sildenafil 10 MG/ML [Revatio] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307429 | sildenafil Oral Suspension [Revatio] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1307430 | Revatio Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307431 | Revatio 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307431 | Revatio 10 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307431 | Revatio 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307431 | Revatio 10 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307431 | Revatio 10 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307539 | Morus nigra root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307540 | Viola odorata flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307541 | Magnolia virginiana flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307542 | Astrocaryum murumuru seed butter extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307543 | Agave tequilana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307544 | Bletilla striata tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307544 | Bletilla striata tuber extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307545 | Morus alba stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307547 | Camellia japonica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307548 | 4-(p-hydroxyphenyl)-2-butanone acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307549 | Cymbopogon citratus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307550 | Polygonatum odoratum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307551 | 3-hydroxy-4-methoxybenzenesulfonic acid | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1307553 | Filipendula ulmaria flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307554 | Artemisia capillaris flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307555 | pyrrobutamine naphthalene disulfonate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307555 | pyrrobutamine naphthalene disulfonate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307556 | Cornus officinalis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307557 | Mentha x rotundifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307558 | aminopropyl ascorbyl phosphate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307560 | Cydonia oblonga seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307561 | Cucumaria sea cucumber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307562 | coconut acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307563 | cucumber juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307564 | Epilobium angustifolium flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307565 | ammonium laureth-2 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307566 | Urtica urens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307567 | Betula platyphylla var japonica resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307568 | Rosa damascena flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307569 | beheneth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307570 | Irvingia gabonensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307571 | 1,4-sorbitan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307572 | Albizia julibrissin bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307573 | Angelica pubescens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307574 | Chenopodium album flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307575 | Sanguisorba minor root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307576 | Alcea rosea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307577 | Coptis japonica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307578 | Oenothera biennis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307579 | Urtica dioica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307580 | Salvia miltiorrhiza root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307581 | Magnolia grandiflora bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307582 | high mallow leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307582 | high mallow leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307583 | butedronate tetrasodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1307585 | Thuja occidentalis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307586 | Paris polyphylla root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307587 | Withania somnifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307588 | cetylpyridinium acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1307589 | Cassia fistula fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307590 | caper berry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307591 | Lonicera dasystyla flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307592 | Ajuga turkestanica top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307593 | Sophora flavescens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307594 | Cedrus atlantica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307595 | Cola acuminata seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307596 | Equisetum arvense branch extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307597 | Selenicereus grandiflorus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307598 | Glycyrrhiza inflata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307599 | Pelargonium graveolens flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307600 | Ipomoea nil seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307601 | Khaya senegalensis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307602 | Morus australis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307603 | Moringa oleifera bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307604 | Malpighia emarginata seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307605 | Theobroma grandiflorum seed butter extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307606 | Avena sativa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307607 | Magnolia biondii bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307609 | Chrysanthemum indicum flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307609 | Chrysanthemum indicum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307610 | Acmella oleracea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307611 | Dioscorea japonica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307612 | Phellodendron chinensis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307613 | Oenothera biennis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307614 | Platycodon grandiflorum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307617 | Duboisia leichhardtii leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307618 | Larrea divaricata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307619 | bosutinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307619 | bosutinib | Designated preferred name (PT) | YES | |
RxCUI: 1307619 | bosutinib | Full form of descriptor (FN) | YES | |
RxCUI: 1307619 | bosutinib | Designated preferred name (PT) | YES | |
RxCUI: 1307619 | bosutinib | Full form of descriptor (FN) | YES | |
RxCUI: 1307620 | bosutinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307621 | bosutinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307621 | bosutinib Oral Product | Designated preferred name (PT) | YES | |
RxCUI: 1307621 | bosutinib Oral Product | Full form of descriptor (FN) | YES | |
RxCUI: 1307622 | bosutinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1307623 | bosutinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
RxCUI: 1307624 | bosutinib 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307624 | bosutinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307624 | bosutinib 100 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1307624 | bosutinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307624 | bosutinib 100 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1307625 | Bosulif | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
RxCUI: 1307626 | bosutinib 100 MG [Bosulif] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307627 | bosutinib Oral Tablet [Bosulif] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
RxCUI: 1307628 | Bosulif Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307629 | Bosulif Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
RxCUI: 1307630 | Bosulif 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307630 | Bosulif 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307630 | Bosulif 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307630 | Bosulif 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307631 | Bambusa arundinacea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307632 | bosutinib 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1307633 | bosutinib 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307633 | bosutinib 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307633 | bosutinib 500 MG Oral Tablet | Designated preferred name (PT) | YES | |
RxCUI: 1307633 | bosutinib 500 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1307633 | bosutinib 500 MG Oral Tablet | Full form of descriptor (FN) | YES | |
RxCUI: 1307634 | bosutinib 500 MG [Bosulif] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1307635 | Bosulif 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307635 | Bosulif 500 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1307635 | Bosulif 500 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307635 | Bosulif 500 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1307636 | Hamamelis virginiana flower water extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307637 | eastern purple coneflower flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307637 | eastern purple coneflower flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307638 | Lepidium meyenii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307639 | Nepeta tenuifolia flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307639 | Nepeta tenuifolia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307640 | neem leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307640 | neem leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307641 | Borago officinalis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307642 | Averrhoa carambola leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307643 | Withania somnifera flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307644 | Eclipta prostrata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307645 | Aspalathus linearis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307646 | Pogostemon cablin top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307647 | Quercus robur twig bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307648 | Annickia chlorantha bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307649 | Artemisia argyi leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307653 | Prunus mume flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307655 | Curcuma longa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307658 | Thymus vulgaris leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307659 | Ligusticum tenuissimum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307660 | Lycium chinense root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307661 | Azadirachta indica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307662 | anhydrous lactose | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307663 | Pinellia ternata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307664 | Angelica gigas root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307665 | Prunus dulcis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307667 | Pulsatilla cernua root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307667 | Pulsatilla cernua root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307668 | Filipendula ulmaria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307669 | Arisaema erubescens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307670 | Persicaria tinctoria leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307671 | Pinus tabuliformis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307672 | Perilla frutescens leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307673 | Echinacea angustifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307674 | Actinidia polygama fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307675 | asparagus cochinchinesis tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307676 | hydrogenated palm oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307677 | Arctium lappa fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307678 | Bambusa vulgaris whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307679 | Chilean hazelnut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307680 | aminomethyl propanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307681 | mango seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307682 | galangal oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307683 | hydrogenated coconut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307684 | Eucalyptus polybractea leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307685 | galbanum oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307686 | Cedrus deodara wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307687 | Pueraria montana var. chinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307688 | PEG-60 hydrogenated castor oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307688 | PEG-60 hydrogenated castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307689 | paprika oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307690 | Amaranthus caudatus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307691 | Mentha arvensis leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307692 | Ononis spinosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307692 | Ononis spinosa root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307693 | rosewood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307694 | FD&C blue #1 aluminum lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307695 | FD&C blue #2 lake | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307696 | Polygonatum multiflorum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307697 | Rubes nigrum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307698 | Sambucus nigra flowering top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307699 | Lawsonia inermis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307700 | PEG-10 rapeseed sterol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307701 | Yucca schidigera root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307702 | Musa x paradisiaca leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307703 | Perilla frutescens seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307704 | Hypericum perforatum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307705 | Pelargonium graveolens flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307706 | Punica granatum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307707 | Flickingeria fimbriata stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307708 | rice germ oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307709 | Dipteryx odorata seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307710 | Crypthecodinium cohnii DHA oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307711 | Juglans nigra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307712 | Morus alba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307713 | Kalopanax septemlobus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307714 | Lilium candidum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307715 | Aquilaria malaccensis stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307716 | Tilia cordata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307717 | cherry juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307718 | wine grape extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307719 | Atractylodes japonica root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307719 | Atractylodes japonica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307720 | Ferula assa-foetida root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307721 | white mulberry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307722 | oat kernel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307723 | Rubus idaeus juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307723 | Rubus idaeus juice | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307724 | Myrciaria dubia seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307726 | Panax ginseng flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307727 | Canna indica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307729 | Paeonia suffruticosa root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307730 | Matricaria recutita flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307731 | Paeonia lactiflora root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307732 | human cord blood hematopoietic progenitor cell | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307733 | cucumber seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307734 | carboxymethylcellulose calcium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1307735 | Cyathula officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307736 | Bupleurum chinense root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307737 | Potentilla erecta root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307738 | Phragmites australis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307739 | Vaccinium angustifolium leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307740 | Helianthus annuus seed wax extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307741 | rapeseed sterol extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307742 | Cuscuta japonica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307743 | Syzygium jambos leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307744 | Rosa gallica flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307745 | Nymphaea alba flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307746 | Lippia citriodora flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307747 | Hibiscus rosa-sinensis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307748 | rice oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307749 | white willow bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307749 | white willow bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307750 | Scutellaria baicalensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307752 | witch hazel bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307752 | witch hazel bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307753 | Lonicera japonica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307754 | Cinnamomum camphora leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307755 | English holly leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307755 | English holly leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307756 | Hamamelis virginiana top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307757 | Ambrosia peruviana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307758 | 1,2-butanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307759 | alligator juniper wood oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307759 | alligator juniper wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307760 | Simmondsia chinensis seed wax extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307761 | 1-decene | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307762 | anhydroxylitol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307763 | Helianthus annuus seedcake extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307764 | 1-vinyl-2-pyrrolidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307765 | calcium ascorbate anhydrous | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1307766 | caprylyl glucoside | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307767 | Lavandula angustifolia subsp. angustifolia flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307767 | Lavandula angustifolia subsp. angustifolia flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307768 | Coccinia grandis fruit extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307769 | fenugreek leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307770 | Betula pubescens resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307772 | Copaifera officinalis resin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307773 | ammonium laureth-3 sulfate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307775 | Mauritia flexuosa fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307777 | Cyperus rotundus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307778 | aluminum distearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307779 | C14-22 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307780 | C20-22 alcohols | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307781 | 1,2-diarachidoyl-sn-glycero-3-phosphocholine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307782 | Syringa vulgaris flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307783 | ceteareth-33 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307784 | Carthamus tinctorius (safflower) oleosomes extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307787 | bancha tea, leaf, twig preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307788 | vetiver oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307789 | Saururus chinensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307790 | Calendula officinalis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307791 | Lithospermum erythrorhizon root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307792 | dihydroxypropyl PEG-5 linoleammonium chloride | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307794 | Panax japonicus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307797 | barium chromate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307800 | Camellia kissii seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307801 | barium oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307802 | Corydalis bungeana flowering-fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307803 | clove stem oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307804 | Hedychium coronarium root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307805 | Litchi chinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307806 | Artemisia umbelliformis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307807 | Ophiopogon japonicus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307808 | Isatis tinctoria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307809 | European hazelnut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307810 | Quercus suber bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307812 | Plumeria rubra flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307814 | Perilla frutescens seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307815 | xanthan gum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307816 | Magnolia acuminata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307817 | Asarum sieboldii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307818 | Camellia sinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307819 | Hamamelis virginiana leaf water extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307820 | Molasses | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307820 | Molasses | Designated preferred name (PT) | NO | |
RxCUI: 1307820 | Molasses | Full form of descriptor (FN) | NO | |
RxCUI: 1307820 | Molasses | British preferred term (PTGB) | NO | |
RxCUI: 1307822 | Plukenetia volubilis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307824 | Senna alata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307825 | Olea europaea fruit volatile oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307826 | Camellia japonica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307827 | Coix lacryma-jobi var. ma-yuen seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307828 | Mangifera indica seed butter extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307829 | PEG-4 rapeseedamide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307830 | carbomer homopolymer type b (allyl sucrose crosslinked) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307830 | carbomer homopolymer type b (allyl sucrose crosslinked) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307831 | Coix lacryma-jobi seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307832 | Alpinia officinarum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307833 | carnauba wax | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307834 | Moringa oleifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307835 | myrtle leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307836 | Melissa officinalis leaf | Designated preferred name (PT) | YES | |
RxCUI: 1307836 | Melissa officinalis leaf | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307836 | Melissa officinalis leaf | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307836 | Melissa officinalis leaf | Full form of descriptor (FN) | YES | |
RxCUI: 1307836 | Melissa officinalis leaf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307837 | Guazuma ulmifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307838 | century plant leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307838 | century plant leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307839 | Clematis vitalba leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307840 | cetostearyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307841 | Maackia floribunda stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307842 | Actinidia chinensis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307843 | Morinda citrifolia seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307844 | Persea americana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307846 | Levant cottonseed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307847 | Lippia citriodora flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307848 | Opuntia ficus-indica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307849 | Camellia oleifera seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307850 | Bulnesia sarmientoi wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307851 | Prunus serotina bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307852 | Mentha aquatica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307853 | Magnolia officinalis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307854 | Achyranthes bidentata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307855 | Piper kadsura stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307856 | Holarrhena pubescens bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307857 | Rhus glabra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307858 | Morinda citrifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307860 | chloroxylenol 4 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307860 | chloroxylenol 4 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307860 | chloroxylenol 4 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307862 | dimethicone 1.6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307862 | dimethicone 1.6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307862 | dimethicone 1.6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307863 | Aleurites moluccana seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307863 | Aleurites moluccana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307864 | Althaea officinalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307866 | Angelica sinensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307867 | dimethicone 11 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307868 | dimethicone 1.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307868 | dimethicone 1.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307868 | dimethicone 1.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307869 | dimethicone 1.8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307869 | dimethicone 1.8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307869 | dimethicone 1.8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307870 | pistachio oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307873 | dimethicone 135 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1307874 | dimethicone 13.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307874 | dimethicone 13.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307874 | dimethicone 13.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307879 | Jasminum officinale flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307886 | Lavandula angustifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307887 | Hamamelis virginiana leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307888 | Melaleuca quinquenervia leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307939 | Litsea oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307942 | Nymphaea caerulea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307943 | Betula pubescens bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307944 | Rhodiola rosea root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307944 | Rhodiola rosea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307945 | Gentiana lutea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307946 | cola nitida seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307946 | cola nitida seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307947 | Phellodendron amurense bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307948 | eastern red cedar wood oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307948 | eastern red cedar wood oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307949 | Saxifraga stolonifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307951 | Levant cottonseed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307952 | neem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307952 | neem extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307953 | lesser galangal root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307954 | Sanguisorba officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307955 | Olea europaea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307956 | macadamia oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307957 | Mimosa tenuiflora bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307960 | honeysuckle flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307960 | honeysuckle flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307960 | honeysuckle flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307961 | Centella asiatica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307964 | Arnica cordifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307965 | Hydrocotyle asiatica extract homeopathic preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307965 | Hydrocotyle asiatica extract homeopathic preparation | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307966 | Vitis vinifera seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307967 | Filipendula ulmaria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307969 | tamarind seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307970 | mullein leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1307970 | mullein leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307971 | Stevia rebaudiuna leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307972 | kalmia latifolia leaf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307974 | Cnidium officinale root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307975 | Paeonia suffruticosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1307976 | Notopterygium incisum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307977 | Nelumbo nucifera leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1307984 | guaiFENesin 800 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307984 | guaiFENesin 800 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307984 | guaiFENesin 800 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1307987 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307987 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307998 | dextromethorphan hydrobromide 25 MG per 5 ML / guaifenesin 225 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1307998 | dextromethorphan hydrobromide 25 MG per 5 ML / guaifenesin 225 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1307998 | dextromethorphan hydrobromide 25 MG per 5 ML / guaifenesin 225 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1307998 | dextromethorphan hydrobromide 25 MG per 5 ML / guaifenesin 225 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308 | Bacteriochlorophyll | Designated preferred name (PT) | NO | |
RxCUI: 1308 | Bacteriochlorophyll | Full form of descriptor (FN) | NO | |
RxCUI: 1308067 | origanum oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1308370 | phenylephrine hydrochloride 7.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1308371 | guaifenesin 200 MG / phenylephrine HCl 7.5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308371 | guaifenesin 200 MG / phenylephrine HCl 7.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308371 | guaifenesin 200 MG / phenylephrine HCl 7.5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308371 | guaifenesin 200 MG / phenylephrine HCl 7.5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308376 | guaiFENesin 400 MG / phenylephrine HCl 15 MG 12HR Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308376 | guaiFENesin 400 MG / phenylephrine HCl 15 MG 12HR Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308376 | guaiFENesin 400 MG / phenylephrine HCl 15 MG 12HR Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1308379 | guaifenesin 400 MG / phenylephrine HCl 15 MG Extended Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308379 | guaifenesin 400 MG / phenylephrine HCl 15 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308379 | guaifenesin 400 MG / phenylephrine HCl 15 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308379 | guaifenesin 400 MG / phenylephrine HCl 15 MG Extended Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308381 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG [PreNexa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1308382 | alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoate / docusate / ferrous fumarate / folic acid / pyridoxine / tricalcium phosphate Oral Capsule [PreNexa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1308383 | PreNexa Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1308384 | PreNexa Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308385 | alpha-tocopherol acetate 30 UNT / ascorbic acid 25 MG / cholecalciferol 170 UNT / docosahexaenoic acid 265 MG / docusate sodium 55 MG / ferrous fumarate 30 MG / folic acid 1.24 MG / pyridoxine hydrochloride 25 MG / tricalcium phosphate 160 MG Oral Capsule [PreNexa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308399 | guaifenesin 400 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308399 | guaifenesin 400 MG / phenylephrine hydrochloride 15 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308404 | alcloxa 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1308405 | alcloxa / chloroxylenol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1308406 | alcloxa / chloroxylenol Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1308407 | alcloxa / chloroxylenol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1308408 | chloroxylenol 5 % / alcloxa 0.25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308408 | chloroxylenol 5 % / alcloxa 0.25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308408 | chloroxylenol 5 % / alcloxa 0.25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1308426 | everolimus Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
RxCUI: 1308428 | everolimus 2 MG Tablet for Oral Suspension | Designated preferred name (PT) | YES | |
RxCUI: 1308428 | everolimus 2 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308428 | everolimus 2 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308428 | everolimus 2 MG Tablet for Oral Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 1308430 | everolimus 3 MG Tablet for Oral Suspension | Designated preferred name (PT) | YES | |
RxCUI: 1308430 | everolimus 3 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308430 | everolimus 3 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308430 | everolimus 3 MG Tablet for Oral Suspension | Full form of descriptor (FN) | YES | |
RxCUI: 1308432 | everolimus 5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308432 | everolimus 5 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308438 | codeine phosphate 10 MG / brompheniramine maleate 2 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308438 | codeine phosphate 10 MG / brompheniramine maleate 2 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308438 | codeine phosphate 10 MG / brompheniramine maleate 2 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1308439 | brompheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML [Nalex AC] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1308440 | brompheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML Oral Solution [Nalex AC] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1308440 | brompheniramine maleate 0.4 MG/ML / codeine phosphate 2 MG/ML Oral Solution [Nalex AC] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308441 | phenyltoloxamine citrate 1.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1308442 | chlorpheniramine maleate 2.5 MG / phenylephrine hydrochloride 5 MG / phenyltoloxamine citrate 7.5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308442 | chlorpheniramine maleate 2.5 MG / phenylephrine hydrochloride 5 MG / phenyltoloxamine citrate 7.5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308445 | dextromethorphan HBr 30 MG / guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308445 | dextromethorphan HBr 30 MG / guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1308445 | dextromethorphan HBr 30 MG / guaiFENesin 800 MG / pseudoephedrine HCl 60 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308448 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308448 | dextromethorphan hydrobromide 30 MG / guaifenesin 800 MG / pseudoephedrine hydrochloride 60 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308458 | hydrocodone bitartrate 1.66 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308458 | hydrocodone bitartrate 1.66 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308458 | hydrocodone bitartrate 1.66 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308458 | hydrocodone bitartrate 1.66 MG / phenylephrine hydrochloride 5 MG per 5 ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308461 | chlorpheniramine maleate 4 MG / phenylephrine hydrochloride 25 MG / phenyltoloxamine citrate 40 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308473 | guaiFENesin 600 MG / dextromethorphan HBr 28 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308473 | guaiFENesin 600 MG / dextromethorphan HBr 28 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308473 | guaiFENesin 600 MG / dextromethorphan HBr 28 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1308476 | dextromethorphan hydrobromide 28 MG / guaifenesin 600 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308476 | dextromethorphan hydrobromide 28 MG / guaifenesin 600 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308484 | dextromethorphan HBr 30 MG / guaiFENesin 575 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308484 | dextromethorphan HBr 30 MG / guaiFENesin 575 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308484 | dextromethorphan HBr 30 MG / guaiFENesin 575 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1308487 | dextromethorphan hydrobromide 30 MG / guaifenesin 575 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1308487 | dextromethorphan hydrobromide 30 MG / guaifenesin 575 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308535 | guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308535 | guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308535 | guaiFENesin 200 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
RxCUI: 1308568 | rivastigmine 0.554 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
RxCUI: 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
RxCUI: 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308569 | rivastigmine 13.3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1308570 | rivastigmine 0.554 MG/HR [Exelon] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
RxCUI: 1308571 | EXELON PATCH 13.3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1308571 | EXELON PATCH 13.3 MG/Day 24HR Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
RxCUI: 1308571 | EXELON PATCH 13.3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1308571 | EXELON PATCH 13.3 MG/Day 24HR Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
RxCUI: 1308571 | EXELON PATCH 13.3 MG/Day 24HR Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1308573 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML [Nalex DH] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1308573 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308574 | hydrocodone / phenylephrine Oral Solution [Nalex DH] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1308574 | hydrocodone / phenylephrine Oral Solution [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308575 | Nalex DH Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1308576 | Nalex DH Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1308577 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1308577 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1308577 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1308577 | hydrocodone bitartrate 0.332 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309062 | acetaminophen 325 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309062 | acetaminophen 325 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309062 | acetaminophen 325 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309062 | acetaminophen 325 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309062 | acetaminophen 325 MG / guaiFENesin 100 MG / phenylephrine HCl 5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309063 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309063 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309065 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [Nalex DH] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1309065 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309069 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1309069 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309069 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309069 | hydrocodone bitartrate 0.5 MG/ML / phenylephrine hydrochloride 1 MG/ML Oral Solution [Nalex DH] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309070 | chlorpheniramine maleate 6 MG / methscopolamine nitrate 2.5 MG / pseudoephedrine hydrochloride 120 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309199 | Aloe barbadensis flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309199 | Aloe barbadensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309200 | Angelica acutiloba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309201 | black pepper oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309202 | canola oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309202 | canola oil | Designated preferred name (PT) | YES | |
RxCUI: 1309202 | canola oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309203 | Bixa orellana seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309204 | dill seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309206 | myrrh oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309207 | Borago officinalis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309208 | grape seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309208 | grape seed oil | Designated preferred name (PT) | YES | |
RxCUI: 1309208 | grape seed oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309209 | Myristica oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309209 | Myristica oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309209 | Myristica oil | Designated preferred name (PT) | YES | |
RxCUI: 1309209 | Myristica oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309209 | Myristica oil | Designated preferred name (PT) | YES | |
RxCUI: 1309209 | Myristica oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309210 | Garlic oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309210 | Garlic oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309210 | Garlic oil | Designated preferred name (PT) | YES | |
RxCUI: 1309210 | Garlic oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309211 | Cajuput oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309211 | Cajuput oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309211 | Cajuput oil | Designated preferred name (PT) | YES | |
RxCUI: 1309211 | Cajuput oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309212 | grapefruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309213 | pennyroyal oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309214 | ylang-ylang oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309214 | ylang-ylang oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309215 | Hibiscus sabdariffa flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309216 | PEG-40 castor oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309216 | PEG-40 castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309217 | Cedar leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309217 | Cedar leaf oil | Designated preferred name (PT) | YES | |
RxCUI: 1309217 | Cedar leaf oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309218 | hydrogenated castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309220 | Rehmannia glutinosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309221 | chamomile flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309222 | hydrogenated soybean oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309223 | rice bran oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309224 | Santal oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309224 | Santal oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309224 | Santal oil | Designated preferred name (PT) | YES | |
RxCUI: 1309224 | Santal oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309224 | Santal oil | Designated preferred name (PT) | YES | |
RxCUI: 1309224 | Santal oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309225 | hydrogenated vegetable oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309226 | Chamomile extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309226 | Chamomile extract | Designated preferred name (PT) | YES | |
RxCUI: 1309226 | Chamomile extract | Full form of descriptor (FN) | YES | |
RxCUI: 1309226 | Chamomile extract | Designated preferred name (PT) | YES | |
RxCUI: 1309226 | Chamomile extract | Full form of descriptor (FN) | YES | |
RxCUI: 1309227 | cinnamon oil, leaf | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309228 | Hypericum | Designated preferred name (PT) | NO | |
RxCUI: 1309228 | Hypericum | Full form of descriptor (FN) | NO | |
RxCUI: 1309228 | Hypericum | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309229 | Cassia oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309229 | Cassia oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309229 | Cassia oil | Designated preferred name (PT) | YES | |
RxCUI: 1309229 | Cassia oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309230 | Orange oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309230 | Orange oil | Designated preferred name (PT) | YES | |
RxCUI: 1309230 | Orange oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309230 | Orange oil | Designated preferred name (PT) | YES | |
RxCUI: 1309230 | Orange oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309231 | selenium dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309232 | clary sage oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309233 | clove leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309235 | 1,10-decanediol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309236 | Parsley seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309236 | Parsley seed oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309237 | Hyssopus officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309237 | Hyssopus officinalis flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309238 | germanium dioxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309239 | Coconut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309239 | Coconut oil | Designated preferred name (PT) | YES | |
RxCUI: 1309239 | Coconut oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309240 | jasmine oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309241 | Coriander oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309241 | Coriander oil | Designated preferred name (PT) | YES | |
RxCUI: 1309241 | Coriander oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309242 | European goldenrod allergenic extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309242 | European goldenrod allergenic extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309243 | Cottonseed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309243 | Cottonseed oil | Designated preferred name (PT) | YES | |
RxCUI: 1309243 | Cottonseed oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309245 | juniper berry oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309246 | polyoxyl 35 castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309247 | Benne oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309247 | Benne oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309247 | Benne oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309247 | Benne oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309247 | Benne oil | Designated preferred name (PT) | YES | |
RxCUI: 1309247 | Benne oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309247 | Benne oil | Designated preferred name (PT) | YES | |
RxCUI: 1309247 | Benne oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309248 | sorbitan olivate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309249 | lanolin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309250 | sweet oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309250 | sweet oil | Designated preferred name (PT) | YES | |
RxCUI: 1309250 | sweet oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309250 | sweet oil | Designated preferred name (PT) | YES | |
RxCUI: 1309250 | sweet oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309250 | sweet oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309252 | palm kernel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309253 | Lemon oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309253 | Lemon oil | Designated preferred name (PT) | YES | |
RxCUI: 1309253 | Lemon oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309253 | Lemon oil | Designated preferred name (PT) | YES | |
RxCUI: 1309253 | Lemon oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309254 | tetrahexyldecyl ascorbate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309255 | quinine arsenate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309255 | quinine arsenate | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309256 | meadowfoam oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309257 | Vaccinium myrtillus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309258 | Simmondsia chinensis oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309258 | Simmondsia chinensis oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309258 | Simmondsia chinensis oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309259 | Achillea millefolium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309259 | Achillea millefolium extract | Full form of descriptor (FN) | NO | |
RxCUI: 1309259 | Achillea millefolium extract | Full form of descriptor (FN) | NO | |
RxCUI: 1309259 | Achillea millefolium extract | Designated preferred name (PT) | NO | |
RxCUI: 1309259 | Achillea millefolium extract | Designated preferred name (PT) | NO | |
RxCUI: 1309259 | Achillea millefolium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309260 | Theobroma grandiflorum seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309279 | Withania somnifera root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309280 | Abies sachalinensis var. sachalinensis oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309281 | Urtica dioica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309282 | acai oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309283 | Uncaria rhynchophylla stem | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309284 | Actaea cimicifuga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309286 | Angelica archangelica leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309287 | Taraxacum officinale leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309288 | Arnica chamissonis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309289 | pot marigold flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309289 | pot marigold flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309290 | Rosa rubiginosa seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309291 | raspberry seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309292 | Anise seed | Designated preferred name (PT) | YES | |
RxCUI: 1309292 | Anise seed | Full form of descriptor (FN) | YES | |
RxCUI: 1309292 | Anise seed | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309293 | carrot seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309294 | Prunella vulgaris flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309295 | Citrus aurantiifolia leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309296 | Piscidia piscipula root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309297 | pyrimethamine 12.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309298 | pyrimethamine / sulfadiazine Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1309298 | pyrimethamine / sulfadiazine Oral Liquid Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309299 | pyrimethamine / sulfadiazine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1309299 | pyrimethamine / sulfadiazine Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309300 | pyrimethamine / sulfadiazine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1309300 | pyrimethamine / sulfadiazine Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309301 | pyrimethamine / sulfadiazine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
RxCUI: 1309301 | pyrimethamine / sulfadiazine | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309302 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309302 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309303 | Rebalance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1309304 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML [Rebalance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1309304 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML [Rebalance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309305 | pyrimethamine / sulfadiazine Oral Suspension [Rebalance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1309305 | pyrimethamine / sulfadiazine Oral Suspension [Rebalance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309306 | Rebalance Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1309307 | Rebalance Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1309308 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension [Rebalance] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1309308 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension [Rebalance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309308 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension [Rebalance] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309308 | pyrimethamine 12.5 MG/ML / sulfadiazine 250 MG/ML Oral Suspension [Rebalance] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
RxCUI: 1309309 | Pinus strobus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309310 | oregano flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309311 | lincomycin 100 MG/ML [Lincocin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1309312 | lincomycin 100 MG/ML Injectable Solution [Lincocin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309312 | lincomycin 100 MG/ML Injectable Solution [Lincocin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1309314 | tulathromycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309314 | tulathromycin | Designated preferred name (PT) | YES | |
RxCUI: 1309314 | tulathromycin | Full form of descriptor (FN) | YES | |
RxCUI: 1309315 | tulathromycin 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309316 | tulathromycin Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
RxCUI: 1309317 | tulathromycin Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
RxCUI: 1309318 | tulathromycin 100 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309318 | tulathromycin 100 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309319 | Draxxin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1309320 | tulathromycin 100 MG/ML [Draxxin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1309321 | tulathromycin Injectable Solution [Draxxin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1309322 | Draxxin Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1309323 | tulathromycin 100 MG/ML Injectable Solution [Draxxin] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309323 | tulathromycin 100 MG/ML Injectable Solution [Draxxin] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1309324 | Artemisia absinthium extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309324 | Artemisia absinthium extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309325 | Notopterygium franhetii root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309326 | peppermint leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309326 | peppermint leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309327 | Mentha arvensis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309328 | Melissa officinalis leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309329 | Cryptocarya agathophylla leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309330 | Melaleuca alternifolia leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309331 | Cupressus sempervirens leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309332 | Matricaria chamomilla flowering top oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309334 | coniferyl alcohol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309336 | cassava | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309336 | cassava | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309337 | Chinese cinnamon oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309338 | East Indian lemongrass oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309339 | thallium sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309340 | dimethicone 14 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309341 | dimethicone 1.4 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309341 | dimethicone 1.4 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309341 | dimethicone 1.4 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309343 | dimethicone 27 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309344 | dimethicone 2.7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309344 | dimethicone 2.7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309344 | dimethicone 2.7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309345 | dimethicone 31 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309346 | dimethicone 3.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309346 | dimethicone 3.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309346 | dimethicone 3.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309347 | geranium oil, Algerian type | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309348 | dimethicone 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309349 | dimethicone 6.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309349 | dimethicone 6.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309349 | dimethicone 6.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309350 | high mallow flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309350 | high mallow flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309351 | Magnolia officinalis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309352 | Magnolia grandiflora flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309353 | Ligusticum sinense root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309354 | Helichrysum italicum flower oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309355 | dimethicone 19 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
RxCUI: 1309356 | dimethicone 1.9 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309356 | dimethicone 1.9 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309356 | dimethicone 1.9 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
RxCUI: 1309357 | Leptospermum petersonii leaf oil extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309358 | Helichrysum italicum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309359 | Hippophae rhamnoides seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309360 | hydrogenated palm kernel oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309361 | Cnidium seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309362 | Hypericum perforatum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309363 | PEG-120 methyl glucose dioleate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309364 | kukui nut oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309365 | peg-20 glyceryl stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309366 | peg-32 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309367 | PEG-6 stearate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309368 | polyethyelene glycol 7000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309370 | Plantago lanceolata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309371 | Rose oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309371 | Rose oil | Designated preferred name (PT) | YES | |
RxCUI: 1309371 | Rose oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309372 | Pogostemon cablin leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309372 | Pogostemon cablin leaf oil | Designated preferred name (PT) | YES | |
RxCUI: 1309372 | Pogostemon cablin leaf oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309372 | Pogostemon cablin leaf oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309372 | Pogostemon cablin leaf oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309373 | Caraway oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309373 | Caraway oil | Designated preferred name (PT) | NO | |
RxCUI: 1309373 | Caraway oil | Full form of descriptor (FN) | NO | |
RxCUI: 1309374 | palmarosa oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309375 | Oil of niaouli | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309375 | Oil of niaouli | Designated preferred name (PT) | NO | |
RxCUI: 1309375 | Oil of niaouli | Full form of descriptor (FN) | NO | |
RxCUI: 1309376 | Citronella oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309376 | Citronella oil | Designated preferred name (PT) | YES | |
RxCUI: 1309376 | Citronella oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309377 | lime oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309385 | lavandin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309387 | costus root oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309388 | Zingiber officinale oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309388 | Zingiber officinale oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309388 | Zingiber officinale oil | Designated preferred name (PT) | YES | |
RxCUI: 1309388 | Zingiber officinale oil | Full form of descriptor (FN) | YES | |
RxCUI: 1309388 | Zingiber officinale oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309389 | emu oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309390 | safflower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309391 | sunflower seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309392 | Alpinia zerumbet leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309394 | Ampelopsis japonica tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309394 | Ampelopsis japonica tuber extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309395 | Acorus calamus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309396 | Vardenafil hydrochloride trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309396 | Vardenafil hydrochloride trihydrate | Designated preferred name (PT) | YES | |
RxCUI: 1309396 | Vardenafil hydrochloride trihydrate | Full form of descriptor (FN) | YES | |
RxCUI: 1309397 | Anacyclus pyrethrum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309398 | Aesculus hippocastanum bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309399 | Chlorobutanol hemihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309399 | Chlorobutanol hemihydrate | Designated preferred name (PT) | YES | |
RxCUI: 1309399 | Chlorobutanol hemihydrate | Full form of descriptor (FN) | YES | |
RxCUI: 1309401 | Aframomum angustifolium seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309402 | floxacillin sodium monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309403 | Anogeissus leiocarpus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309404 | Ipratropium bromide monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309404 | Ipratropium bromide monohydrate | Designated preferred name (PT) | NO | |
RxCUI: 1309404 | Ipratropium bromide monohydrate | Full form of descriptor (FN) | NO | |
RxCUI: 1309405 | Ardisia japonica stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309406 | Acer saccharum bark-sap extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309407 | Betula platyphylla var. japonica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309408 | zinc valerate dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309410 | zinc sulfate monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309411 | Artemisia princeps leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309412 | Bupleurum falcatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309413 | Asclepias tuberosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309414 | Camellia japonica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309415 | Carica papaya leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309417 | Carex humilis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309418 | Centaurea cyanus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309419 | Dioscorea collettii var. hypoglauca root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309420 | Cupressus sempervirens seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309421 | Drynaria fortunei root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309422 | Cymbopogon schoenanthus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309423 | Diospyros kaki leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309424 | frankincense oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309425 | Epilobium angustifolium leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309426 | Gardenia taitensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309427 | Gentiana macrophylla root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309428 | Gentianella amarella flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309429 | wasabi root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309431 | Glehnia littoralis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309432 | Ilex pubescens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309433 | Imperata cylindrica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309434 | Lamium album flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309435 | Lapsana communis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309436 | Lathyrus odoratus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309437 | Lavandula stoechas flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309438 | Leontopodium alpinum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309439 | Leontopodium alpinum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309440 | Magnolia obovata bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309441 | Berberis aquifolium root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309441 | Berberis aquifolium root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309442 | Moringa oleifera seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309443 | Moringa oleifera seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309444 | Morus alba bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309445 | Myrtus communis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309446 | Narcissus pseudonarcissus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309447 | sacred lotus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309447 | sacred lotus flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309448 | Nelumbo nucifera seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309449 | Oenothera biennis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309450 | Oenothera biennis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309451 | Opuntia ficus-indica stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309452 | Macropiper methysticum root | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309452 | Macropiper methysticum root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309453 | Platycladus orientalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309454 | Coleus barbatus root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309454 | Coleus barbatus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309455 | plum seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309456 | Polygonum bistorta root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309457 | Reynoutria japonica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309457 | Reynoutria japonica root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309458 | Prunus armeniaca seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309459 | Salix alba leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309460 | chia seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309460 | chia seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309461 | Sambucus nigra subsp. canadensis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309462 | Saponaria officinalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309463 | Dolomiaea costus root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309463 | Dolomiaea costus root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309463 | Dolomiaea costus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309464 | Fagus sylvatica flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309465 | IL-9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309465 | IL-9 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309465 | IL-9 | Designated preferred name (PT) | NO | |
RxCUI: 1309465 | IL-9 | Full form of descriptor (FN) | NO | |
RxCUI: 1309465 | IL-9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309466 | Fagus sylvatica flowering top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309467 | Hottonia palustris flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309468 | Schinus molle bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309469 | Houttuynia cordata flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309470 | Simmondsia chinesis seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309471 | Sinapsis arvensis flowering-fruiting top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309472 | Humulus lupulus stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309473 | Smilax aristolochiaefolia root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309474 | Tagetes erecta flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309475 | Hydrangea arborescens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309476 | Tanacetum parthenium flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309477 | tea leaf oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309478 | hydrogenated cottonseed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309479 | Thymus oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309480 | Tussilago farfara flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309481 | hydrogenated menhaden oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309483 | Ulmus procera flowering twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309484 | Ulmus rubra bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309485 | Vitis vinifera flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309486 | Vitis vinifera fruit oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309487 | Machilus thunbergii bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309488 | high mallow flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309488 | high mallow flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309489 | Ocimum basilicum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309490 | Panax ginseng root water extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309491 | Passiflora incarnata seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309492 | Melissa officinalis seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309492 | Melissa officinalis seed oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309493 | Perilla frutescens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309494 | avocado seed butter | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309494 | avocado seed butter | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309495 | Petiveria alliacea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309496 | Actaea spicata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309497 | Aesculus hippocastanum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309498 | Aesculus hippocastanum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309499 | Agathosma betulina leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309500 | Rorippa nasturtium-aquaticum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309501 | Agrimonia eupatoria flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309502 | Rosa gallica flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309503 | cape aloe leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309503 | cape aloe leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309504 | Agrimonia eupatoria flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309505 | Salvia rosmarinus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309505 | Salvia rosmarinus flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309506 | Apocynum cannabinum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309507 | Rubus fruticosus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309509 | Ruscus aculeatus root | Designated preferred name (PT) | NO | |
RxCUI: 1309509 | Ruscus aculeatus root | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309509 | Ruscus aculeatus root | Full form of descriptor (FN) | NO | |
RxCUI: 1309509 | Ruscus aculeatus root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309510 | Artemisia cina flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309513 | shark preparation | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309664 | Sassafras oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309664 | Sassafras oil | Designated preferred name (PT) | NO | |
RxCUI: 1309664 | Sassafras oil | Full form of descriptor (FN) | NO | |
RxCUI: 1309665 | Croton oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309665 | Croton oil | Designated preferred name (PT) | NO | |
RxCUI: 1309665 | Croton oil | Full form of descriptor (FN) | NO | |
RxCUI: 1309666 | Cinchona bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309667 | Cinchona pubescens bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309669 | Ephedra distachya flowering twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309670 | sarsaparilla root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309672 | Artemisia maritima flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309673 | eastern poison oak leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309673 | eastern poison oak leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309676 | Bryonia alba root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309677 | Delphinium staphisagria seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309678 | Strychnos nux-vomica seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309680 | CLMF | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309680 | CLMF | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309680 | CLMF | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309680 | CLMF | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309680 | CLMF | Designated preferred name (PT) | NO | |
RxCUI: 1309680 | CLMF | Full form of descriptor (FN) | NO | |
RxCUI: 1309681 | Bambusa vulgaris leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309682 | Veratrum album root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309683 | Grindelia camporum top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309683 | Grindelia camporum top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309684 | Strophanthus hispidus seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309685 | Ruta graveolens flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309686 | Helianthus annuus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309689 | Histidine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309689 | Histidine hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309689 | Histidine hydrochloride | Designated preferred name (PT) | YES | |
RxCUI: 1309689 | Histidine hydrochloride | Full form of descriptor (FN) | YES | |
RxCUI: 1309689 | Histidine hydrochloride | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309690 | Dioscorea villosa tuber extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309691 | arsenic triiodide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309692 | Strychnos ignatii seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309694 | Selenicereus grandiflorus stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309695 | Gelsemium sempervirens root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309697 | witch hazel root bark-stem bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309697 | witch hazel root bark-stem bark extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309699 | Lactuca virosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309701 | Jatropha curcas seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309702 | oat flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309702 | oat flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309703 | malvin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309704 | Justicia adhatoda leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309706 | Ipomoea purga root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309710 | Neopicrorhiza scrophulariiflora root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309711 | Phytolacca americana root extract | Designated preferred name (PT) | YES | |
RxCUI: 1309711 | Phytolacca americana root extract | Full form of descriptor (FN) | YES | |
RxCUI: 1309711 | Phytolacca americana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309713 | Ptelea trifoliata bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309714 | Croton tiglium seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309716 | Verbascum phlomoides flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309717 | Rhododendron chrysanthum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309717 | Rhododendron chrysanthum leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309718 | methacrylic acid - ethyl acrylate copolymer (1:1) type A | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309719 | Juniperus sabina leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309720 | methacrylic acid - methyl methacrylate copolymer (1:1) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309721 | methacrylic acid copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309722 | Alchemilla xanthochlora flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309723 | elecampane inula root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309723 | elecampane inula root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309724 | methacrylic acid - methyl methacrylate copolymer (1:2) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309725 | poly(lactic-co-glycolic acid) (50/50, 0.45-0.6 dL/g inherent viscosity) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309726 | polylactic acid-polyglycolic acid copolymer | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309727 | Salvia rosmarinus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309727 | Salvia rosmarinus flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309728 | poly(dl-lactic-co-glycolic acid), (50:50; 63000 mw) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309729 | Potentilla anserina flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309729 | Potentilla anserina flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309730 | poly(lactic-co-glycolic acid) (75/25, 0.23-0.26 dL/g inherent viscosity) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309732 | poly(lactic-co-glycolic acid) (85/15, 0.25-0.27 dL/g inherent viscosity) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
RxCUI: 1309733 | polyacrylic acid (250000 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309735 | Aristolochia clematitis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309736 | polyacrylic acid (800000 MW) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
RxCUI: 1309737 | Veratrum viride root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309738 | Cochlearia officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309739 | Centaurium erythraea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309741 | phenethylamine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309743 | Malus sylvestris flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309745 | Rosa canina flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309746 | Thuja plicata leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309747 | Cervus elaphus horn oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309748 | Clematis vitalba pre-flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309748 | Clematis vitalba pre-flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309749 | heather flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309749 | heather flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309750 | Juglans cinerea branch bark-root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309751 | Pueraria montana var. lobata root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309752 | Iris germanica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309753 | Quercus robur flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309754 | Thuja occidentalis leafy twig extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309757 | Ceanothus americanus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309758 | Toxicodendron radicans leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309759 | Chionanthus virginicus bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309761 | Poison sumac extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309761 | Poison sumac extract | Designated preferred name (PT) | NO | |
RxCUI: 1309761 | Poison sumac extract | Full form of descriptor (FN) | NO | |
RxCUI: 1309761 | Poison sumac extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309762 | Nuphar luteum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309763 | Solidago virgaurea flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309764 | Krameria lappacea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309766 | Berberis vulgaris root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309767 | Pteridium aquilinum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309768 | Astragalus nuttallii leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309770 | Aesculus carnea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309771 | Cinchona officinalis bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309772 | Citrullus colocynthis fruit pulp extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309774 | Clematis recta flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309775 | Calendula officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309776 | Clematis virginiana top | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309779 | Baptisia tinctoria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309780 | Clerodendranthus spicatus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309781 | Sanicula europaea leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309782 | Collinsonia canadensis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309783 | Eupatorium perfoliatum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309785 | Gossypium herbaceum root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309786 | Platycodon grandiflorum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309788 | Eucommia ulmoides bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309789 | Arum maculatum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309791 | Eutrochium purpureum root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309793 | hawthorn leaf with flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309794 | Ceratostigma willmottianum flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309795 | Hedera helix leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309796 | Tabebuia heterophylla bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309798 | quebracho bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309799 | Ligusticum porteri root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309800 | Arundo pliniana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309803 | Ligusticum sinense subsp. chuanxiong root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309805 | Asclepias tuberosa flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309806 | Ligusticum tenuissimum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309807 | Vincetoxicum hirundinaria root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309807 | Vincetoxicum hirundinaria root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309808 | Ferula sumbul root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309809 | Malus pumila flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309809 | Malus pumila flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309810 | Thuja occidentalis leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309811 | Garcinia indica seed butter extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309812 | Aspidosperma quebracho-blanco bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309813 | Tsuga canadensis flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309814 | Astragalus propinquus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309815 | Betula pendula bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309816 | Prunus spinosa flower bud extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309818 | European hornbeam flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309818 | European hornbeam flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309819 | Betula pubescens leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309820 | European cranberrybush root | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309820 | European cranberrybush root | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309822 | Cichorium intybus flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309823 | Tilia x europaea flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309825 | Vincetoxicum indicum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309825 | Vincetoxicum indicum root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309826 | Medicago sativa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309827 | Morella cerifera root bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309828 | Norwegian angelica root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309828 | Norwegian angelica root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309829 | Verbena officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309830 | Apocynum androsaemifolium root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309831 | Ocimum americanum leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309832 | Iris pallida root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309833 | Aralia racemosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309928 | Solidago canadensis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309929 | white clover flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309929 | white clover flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309932 | Daphne odora bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309934 | Frangula californica bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309936 | Castanea sativa flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309937 | Lathyrus sativas seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309939 | Sorghum bicolor stem juice | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309940 | Reynoutria multiflora root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309940 | Reynoutria multiflora root extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309942 | desert Indianwheat seed extract | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
RxCUI: 1309942 | desert Indianwheat seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309943 | Arnica angustifolia flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309946 | Mimulus guttatus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309947 | Arnica montana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309948 | Quillaja saponaria bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309949 | Strychnos wallichiana bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309950 | Aletris farinosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309951 | Abrus precatorius seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309952 | Veronica officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309953 | Prunus speciosa leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309954 | Arisaema triphyllum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309955 | Viburnum prunifolium bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309956 | Vetiveria zizanioides root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309958 | Camellia sinensis flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309959 | Alpinia galanga leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309960 | Iberis amara seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309961 | English holly flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309961 | English holly flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309966 | Cananga odorata flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309968 | Cardiospermum halicacabum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309969 | Hemidesmus indicus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309971 | Robinia pseudoacacia bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309972 | polyoxyl 60 castor oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309973 | Rubia tinctorum root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309974 | Reversion Acne Control Clarifying Cleanser | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
RxCUI: 1309975 | salicylic acid 10 MG/ML [Reversion Acne Control Clarifying Cleanser] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
RxCUI: 1309976 | salicylic acid Medicated Liquid Soap [Reversion Acne Control Clarifying Cleanser] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
RxCUI: 1309977 | Reversion Acne Control Clarifying Cleanser Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
RxCUI: 1309978 | re:version Acne Control 1 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
RxCUI: 1309978 | re:version Acne Control 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309978 | re:version Acne Control 1 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309978 | re:version Acne Control 1 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
RxCUI: 1309979 | passiflora incarnata flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309980 | soybean seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309981 | Rubus idaeus leaf extract | Designated preferred name (PT) | NO | |
RxCUI: 1309981 | Rubus idaeus leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309981 | Rubus idaeus leaf extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309981 | Rubus idaeus leaf extract | Full form of descriptor (FN) | NO | |
RxCUI: 1309983 | Symplocarpus foetidus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309985 | Taraxacum palustre root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309986 | Fraxinus excelsior leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309987 | Eupatorium cannabinum flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309987 | Eupatorium cannabinum flowering top extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309988 | Morus alba leaf extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309989 | celery seed extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309990 | Helleborus niger root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309991 | Thuja occidentalis root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309992 | Fumaria officinalis flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309993 | Ulmus davidiana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309994 | European hornbeam flower extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309994 | European hornbeam flower extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
RxCUI: 1309996 | Fraxinus excelsior bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
RxCUI: 1309997 | Cedrelopsis grevei bark extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
RxCUI: 1309999 | Ganoderma lucidum stem extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |